1 | Level2 | GO:0009987 | cellular process | 920 | 106 | 12581 | 12673 | 1.84e-158 | 0.90 | 0.50 | 1.8 |
2 | Level2 | GO:0008152 | metabolic process | 768 | 258 | 8925 | 16329 | 1.17e-140 | 0.75 | 0.35 | 2.1 |
3 | Level3 | GO:0044237 | cellular metabolic process | 721 | 305 | 8197 | 17057 | 1.16e-129 | 0.70 | 0.32 | 2.2 |
4 | Level2 | GO:0032502 | developmental process | 462 | 564 | 3683 | 21571 | 4.01e-114 | 0.45 | 0.15 | 3.1 |
5 | Level3 | GO:0044238 | primary metabolic process | 691 | 335 | 8164 | 17090 | 1.74e-111 | 0.67 | 0.32 | 2.1 |
6 | Level2 | GO:0065007 | biological regulation | 557 | 469 | 5705 | 19549 | 5.03e-102 | 0.54 | 0.23 | 2.4 |
7 | Level2 | GO:0050896 | response to stimulus | 432 | 594 | 3524 | 21730 | 1.49e-101 | 0.42 | 0.14 | 3.0 |
8 | Level3 | GO:0007154 | cell communication | 484 | 542 | 4781 | 20473 | 1.08e-88 | 0.47 | 0.19 | 2.5 |
9 | Level2 | GO:0032501 | multicellular organismal process | 462 | 564 | 4429 | 20825 | 1.83e-87 | 0.45 | 0.18 | 2.6 |
10 | Level3 | GO:0006950 | response to stress | 268 | 758 | 1572 | 23682 | 6.81e-85 | 0.26 | 0.06 | 4.2 |
11 | Level4 | GO:0048518 | positive regulation of biological process | 255 | 771 | 1429 | 23825 | 4.31e-84 | 0.25 | 0.06 | 4.4 |
12 | Level3 | GO:0048856 | anatomical structure development | 335 | 691 | 2500 | 22754 | 1.56e-83 | 0.33 | 0.10 | 3.3 |
13 | Level3 | GO:0048869 | cellular developmental process | 311 | 715 | 2205 | 23049 | 1.49e-81 | 0.30 | 0.09 | 3.5 |
14 | Level4 | GO:0030154 | cell differentiation | 311 | 715 | 2205 | 23049 | 1.49e-81 | 0.30 | 0.09 | 3.5 |
15 | Level3 | GO:0065008 | regulation of biological quality | 251 | 775 | 1457 | 23797 | 8.34e-80 | 0.24 | 0.06 | 4.2 |
16 | Level5 | GO:0048522 | positive regulation of cellular process | 237 | 789 | 1298 | 23956 | 2.26e-79 | 0.23 | 0.05 | 4.5 |
17 | Level3 | GO:0050789 | regulation of biological process | 481 | 545 | 5055 | 20199 | 3.74e-79 | 0.47 | 0.20 | 2.3 |
18 | Level4 | GO:0048731 | system development | 302 | 724 | 2206 | 23048 | 4.72e-76 | 0.29 | 0.09 | 3.4 |
19 | Level3 | GO:0048468 | cell development | 249 | 777 | 1519 | 23735 | 3.63e-75 | 0.24 | 0.06 | 4.0 |
20 | Level4 | GO:0007165 | signal transduction | 436 | 590 | 4400 | 20854 | 2.60e-74 | 0.42 | 0.17 | 2.4 |
21 | Level4 | GO:0048513 | organ development | 258 | 768 | 1653 | 23601 | 3.66e-74 | 0.25 | 0.07 | 3.8 |
22 | Level3 | GO:0007275 | multicellular organismal development | 340 | 686 | 2827 | 22427 | 9.99e-74 | 0.33 | 0.11 | 3.0 |
23 | Level3 | GO:0016265 | death | 193 | 833 | 985 | 24269 | 4.69e-68 | 0.19 | 0.04 | 4.8 |
24 | Level4 | GO:0008219 | cell death | 193 | 833 | 985 | 24269 | 4.69e-68 | 0.19 | 0.04 | 4.8 |
25 | Level5 | GO:0012501 | programmed cell death | 188 | 838 | 934 | 24320 | 7.93e-68 | 0.18 | 0.04 | 5.0 |
26 | Level4 | GO:0050793 | regulation of developmental process | 193 | 833 | 995 | 24259 | 1.99e-67 | 0.19 | 0.04 | 4.8 |
27 | Level4 | GO:0050794 | regulation of cellular process | 439 | 587 | 4741 | 20513 | 1.44e-66 | 0.43 | 0.19 | 2.3 |
28 | Level4 | GO:0048519 | negative regulation of biological process | 228 | 798 | 1466 | 23788 | 1.62e-64 | 0.22 | 0.06 | 3.8 |
29 | Level3 | GO:0042221 | response to chemical stimulus | 172 | 854 | 827 | 24427 | 1.32e-63 | 0.17 | 0.03 | 5.1 |
30 | Level3 | GO:0008283 | cell proliferation | 185 | 841 | 987 | 24267 | 1.87e-62 | 0.18 | 0.04 | 4.6 |
31 | Level4 | GO:0006082 | organic acid metabolic process | 143 | 883 | 632 | 24622 | 1.89e-56 | 0.14 | 0.03 | 5.6 |
32 | Level5 | GO:0019752 | carboxylic acid metabolic process | 142 | 884 | 629 | 24625 | 6.10e-56 | 0.14 | 0.02 | 5.6 |
33 | Level3 | GO:0009605 | response to external stimulus | 172 | 854 | 962 | 24292 | 2.75e-55 | 0.17 | 0.04 | 4.4 |
34 | Level5 | GO:0043067 | regulation of programmed cell death | 143 | 883 | 654 | 24600 | 7.26e-55 | 0.14 | 0.03 | 5.4 |
35 | Level5 | GO:0048523 | negative regulation of cellular process | 202 | 824 | 1352 | 23902 | 3.83e-54 | 0.20 | 0.05 | 3.7 |
36 | Level3 | GO:0043170 | macromolecule metabolic process | 534 | 492 | 7238 | 18016 | 4.69e-53 | 0.52 | 0.29 | 1.8 |
37 | Level2 | GO:0051179 | localization | 357 | 669 | 3860 | 21394 | 5.86e-51 | 0.35 | 0.15 | 2.3 |
38 | Level4 | GO:0019538 | protein metabolic process | 355 | 671 | 3837 | 21417 | 1.32e-50 | 0.35 | 0.15 | 2.3 |
39 | Level5 | GO:0007242 | intracellular signaling cascade | 226 | 800 | 1789 | 23465 | 1.23e-49 | 0.22 | 0.07 | 3.1 |
40 | Level5 | GO:0042127 | regulation of cell proliferation | 134 | 892 | 644 | 24610 | 3.31e-49 | 0.13 | 0.03 | 5.1 |
41 | Level4 | GO:0042592 | homeostatic process | 146 | 880 | 807 | 24447 | 3.27e-47 | 0.14 | 0.03 | 4.5 |
42 | Level4 | GO:0044260 | cellular macromolecule metabolic process | 339 | 687 | 3710 | 21544 | 8.61e-47 | 0.33 | 0.15 | 2.2 |
43 | Level3 | GO:0009056 | catabolic process | 150 | 876 | 878 | 24376 | 7.60e-46 | 0.15 | 0.03 | 4.2 |
44 | Level5 | GO:0051093 | negative regulation of developmental process | 107 | 919 | 437 | 24817 | 7.79e-45 | 0.10 | 0.02 | 6.0 |
45 | Level4 | GO:0006793 | phosphorus metabolic process | 175 | 851 | 1222 | 24032 | 2.76e-44 | 0.17 | 0.05 | 3.5 |
46 | Level5 | GO:0006796 | phosphate metabolic process | 175 | 851 | 1222 | 24032 | 2.76e-44 | 0.17 | 0.05 | 3.5 |
47 | Level4 | GO:0009653 | anatomical structure morphogenesis | 177 | 849 | 1260 | 23994 | 8.60e-44 | 0.17 | 0.05 | 3.5 |
48 | Level2 | GO:0002376 | immune system process | 166 | 860 | 1117 | 24137 | 9.01e-44 | 0.16 | 0.04 | 3.7 |
49 | Level5 | GO:0044267 | cellular protein metabolic process | 325 | 701 | 3588 | 21666 | 1.11e-43 | 0.32 | 0.14 | 2.2 |
50 | Level4 | GO:0009611 | response to wounding | 125 | 901 | 639 | 24615 | 2.14e-43 | 0.12 | 0.03 | 4.8 |
51 | Level4 | GO:0044248 | cellular catabolic process | 131 | 895 | 720 | 24534 | 1.66e-42 | 0.13 | 0.03 | 4.5 |
52 | Level4 | GO:0007267 | cell\-cell signaling | 136 | 890 | 813 | 24441 | 1.37e-40 | 0.13 | 0.03 | 4.1 |
53 | Level4 | GO:0006629 | lipid metabolic process | 133 | 893 | 868 | 24386 | 4.16e-36 | 0.13 | 0.03 | 3.8 |
54 | Level4 | GO:0006066 | alcohol metabolic process | 94 | 932 | 436 | 24818 | 1.44e-35 | 0.09 | 0.02 | 5.3 |
55 | Level3 | GO:0065009 | regulation of molecular function | 117 | 909 | 687 | 24567 | 1.60e-35 | 0.11 | 0.03 | 4.2 |
56 | Level5 | GO:0043412 | biopolymer modification | 217 | 809 | 2096 | 23158 | 3.26e-35 | 0.21 | 0.08 | 2.5 |
57 | Level5 | GO:0009893 | positive regulation of metabolic process | 105 | 921 | 560 | 24694 | 4.86e-35 | 0.10 | 0.02 | 4.6 |
58 | Level3 | GO:0009058 | biosynthetic process | 345 | 681 | 4386 | 20868 | 1.72e-34 | 0.34 | 0.17 | 1.9 |
59 | Level4 | GO:0044255 | cellular lipid metabolic process | 117 | 909 | 717 | 24537 | 5.52e-34 | 0.11 | 0.03 | 4.0 |
60 | Level5 | GO:0009887 | organ morphogenesis | 101 | 925 | 546 | 24708 | 2.74e-33 | 0.10 | 0.02 | 4.6 |
61 | Level4 | GO:0043283 | biopolymer metabolic process | 405 | 621 | 5650 | 19604 | 3.11e-33 | 0.39 | 0.22 | 1.8 |
62 | Level4 | GO:0006091 | generation of precursor metabolites and energy | 77 | 949 | 308 | 24946 | 6.40e-33 | 0.08 | 0.01 | 6.2 |
63 | Level5 | GO:0007166 | cell surface receptor linked signal transduction | 225 | 801 | 2314 | 22940 | 6.57e-33 | 0.22 | 0.09 | 2.4 |
64 | Level3 | GO:0006928 | cell motility | 101 | 925 | 572 | 24682 | 7.98e-32 | 0.10 | 0.02 | 4.3 |
65 | Level3 | GO:0051674 | localization of cell | 101 | 925 | 572 | 24682 | 7.98e-32 | 0.10 | 0.02 | 4.3 |
66 | Level3 | GO:0016043 | cellular component organization and biogenesis | 260 | 766 | 2963 | 22291 | 1.58e-31 | 0.25 | 0.12 | 2.2 |
67 | Level2 | GO:0051234 | establishment of localization | 284 | 742 | 3397 | 21857 | 1.89e-31 | 0.28 | 0.13 | 2.1 |
68 | Level4 | GO:0044249 | cellular biosynthetic process | 153 | 873 | 1261 | 23993 | 3.87e-31 | 0.15 | 0.05 | 3.0 |
69 | Level4 | GO:0006954 | inflammatory response | 86 | 940 | 432 | 24822 | 2.06e-30 | 0.08 | 0.02 | 4.9 |
70 | Level5 | GO:0051094 | positive regulation of developmental process | 87 | 939 | 443 | 24811 | 2.20e-30 | 0.08 | 0.02 | 4.8 |
71 | Level5 | GO:0048878 | chemical homeostasis | 84 | 942 | 415 | 24839 | 3.66e-30 | 0.08 | 0.02 | 5.0 |
72 | Level5 | GO:0019725 | cellular homeostasis | 84 | 942 | 421 | 24833 | 8.81e-30 | 0.08 | 0.02 | 4.9 |
73 | Level4 | GO:0035295 | tube development | 63 | 963 | 225 | 25029 | 2.01e-29 | 0.06 | 0.01 | 6.9 |
74 | Level5 | GO:0005996 | monosaccharide metabolic process | 60 | 966 | 205 | 25049 | 6.16e-29 | 0.06 | 0.01 | 7.2 |
75 | Level3 | GO:0006807 | nitrogen compound metabolic process | 89 | 937 | 490 | 24764 | 6.86e-29 | 0.09 | 0.02 | 4.5 |
76 | Level4 | GO:0003013 | circulatory system process | 64 | 962 | 240 | 25014 | 7.35e-29 | 0.06 | 0.01 | 6.6 |
77 | Level5 | GO:0008015 | blood circulation | 64 | 962 | 240 | 25014 | 7.35e-29 | 0.06 | 0.01 | 6.6 |
78 | Level3 | GO:0001775 | cell activation | 69 | 957 | 286 | 24968 | 8.39e-29 | 0.07 | 0.01 | 5.9 |
79 | Level4 | GO:0051239 | regulation of multicellular organismal process | 73 | 953 | 326 | 24928 | 1.14e-28 | 0.07 | 0.01 | 5.5 |
80 | Level4 | GO:0044262 | cellular carbohydrate metabolic process | 79 | 947 | 391 | 24863 | 2.27e-28 | 0.08 | 0.02 | 5.0 |
81 | Level4 | GO:0005975 | carbohydrate metabolic process | 96 | 930 | 582 | 24672 | 2.93e-28 | 0.09 | 0.02 | 4.1 |
82 | Level3 | GO:0006952 | defense response | 114 | 912 | 805 | 24449 | 2.97e-28 | 0.11 | 0.03 | 3.5 |
83 | Level3 | GO:0003008 | system process | 175 | 851 | 1689 | 23565 | 4.08e-28 | 0.17 | 0.07 | 2.6 |
84 | Level5 | GO:0006631 | fatty acid metabolic process | 61 | 965 | 227 | 25027 | 1.04e-27 | 0.06 | 0.01 | 6.6 |
85 | Level4 | GO:0050790 | regulation of catalytic activity | 96 | 930 | 604 | 24650 | 3.55e-27 | 0.09 | 0.02 | 3.9 |
86 | Level5 | GO:0043085 | positive regulation of catalytic activity | 69 | 957 | 311 | 24943 | 5.99e-27 | 0.07 | 0.01 | 5.5 |
87 | Level3 | GO:0006810 | transport | 263 | 763 | 3274 | 21980 | 2.06e-26 | 0.26 | 0.13 | 2.0 |
88 | Level5 | GO:0001944 | vasculature development | 61 | 965 | 244 | 25010 | 2.76e-26 | 0.06 | 0.01 | 6.2 |
89 | Level3 | GO:0006955 | immune response | 114 | 912 | 855 | 24399 | 3.02e-26 | 0.11 | 0.03 | 3.3 |
90 | Level4 | GO:0045321 | leukocyte activation | 61 | 965 | 251 | 25003 | 9.92e-26 | 0.06 | 0.01 | 6.0 |
91 | Level5 | GO:0048646 | anatomical structure formation | 57 | 969 | 219 | 25035 | 2.23e-25 | 0.06 | 0.01 | 6.4 |
92 | Level4 | GO:0019222 | regulation of metabolic process | 259 | 767 | 3284 | 21970 | 8.21e-25 | 0.25 | 0.13 | 1.9 |
93 | Level4 | GO:0051186 | cofactor metabolic process | 56 | 970 | 223 | 25031 | 2.63e-24 | 0.05 | 0.01 | 6.2 |
94 | Level2 | GO:0022610 | biological adhesion | 121 | 905 | 1016 | 24238 | 5.83e-24 | 0.12 | 0.04 | 2.9 |
95 | Level3 | GO:0007155 | cell adhesion | 121 | 905 | 1016 | 24238 | 5.83e-24 | 0.12 | 0.04 | 2.9 |
96 | Level4 | GO:0001666 | response to hypoxia | 36 | 990 | 74 | 25180 | 8.79e-24 | 0.04 | 0.00 | 12.0 |
97 | Level5 | GO:0031323 | regulation of cellular metabolic process | 252 | 774 | 3210 | 22044 | 9.39e-24 | 0.25 | 0.13 | 1.9 |
98 | Level5 | GO:0035239 | tube morphogenesis | 48 | 978 | 162 | 25092 | 1.40e-23 | 0.05 | 0.01 | 7.3 |
99 | Level5 | GO:0006732 | coenzyme metabolic process | 46 | 980 | 146 | 25108 | 1.44e-23 | 0.04 | 0.01 | 7.8 |
100 | Level2 | GO:0008371 | obsolete biological process | 72 | 954 | 406 | 24848 | 5.27e-23 | 0.07 | 0.02 | 4.4 |
101 | Level3 | GO:0006118 | electron transport | 70 | 956 | 386 | 24868 | 7.05e-23 | 0.07 | 0.02 | 4.5 |
102 | Level4 | GO:0016477 | cell migration | 68 | 958 | 369 | 24885 | 1.36e-22 | 0.07 | 0.01 | 4.5 |
103 | Level5 | GO:0046649 | lymphocyte activation | 53 | 973 | 223 | 25031 | 3.94e-22 | 0.05 | 0.01 | 5.8 |
104 | Level4 | GO:0009308 | amine metabolic process | 74 | 952 | 448 | 24806 | 5.28e-22 | 0.07 | 0.02 | 4.1 |
105 | Level5 | GO:0051338 | regulation of transferase activity | 61 | 965 | 306 | 24948 | 6.99e-22 | 0.06 | 0.01 | 4.9 |
106 | Level4 | GO:0006979 | response to oxidative stress | 41 | 985 | 124 | 25130 | 8.59e-22 | 0.04 | 0.00 | 8.1 |
107 | Level4 | GO:0006519 | amino acid and derivative metabolic process | 68 | 958 | 392 | 24862 | 2.53e-21 | 0.07 | 0.02 | 4.3 |
108 | Level4 | GO:0006996 | organelle organization and biogenesis | 143 | 883 | 1453 | 23801 | 5.71e-21 | 0.14 | 0.06 | 2.4 |
109 | Level5 | GO:0009966 | regulation of signal transduction | 89 | 937 | 662 | 24592 | 7.74e-21 | 0.09 | 0.03 | 3.3 |
110 | Level3 | GO:0009719 | response to endogenous stimulus | 41 | 985 | 134 | 25120 | 9.26e-21 | 0.04 | 0.01 | 7.5 |
111 | Level5 | GO:0002520 | immune system development | 56 | 970 | 274 | 24980 | 1.26e-20 | 0.05 | 0.01 | 5.0 |
112 | Level5 | GO:0048534 | hemopoietic or lymphoid organ development | 54 | 972 | 258 | 24996 | 2.44e-20 | 0.05 | 0.01 | 5.2 |
113 | Level3 | GO:0007610 | behavior | 74 | 952 | 497 | 24757 | 1.07e-19 | 0.07 | 0.02 | 3.7 |
114 | Level5 | GO:0007399 | nervous system development | 108 | 918 | 966 | 24288 | 1.45e-19 | 0.11 | 0.04 | 2.8 |
115 | Level5 | GO:0019226 | transmission of nerve impulse | 68 | 958 | 435 | 24819 | 3.57e-19 | 0.07 | 0.02 | 3.8 |
116 | Level4 | GO:0032879 | regulation of localization | 50 | 976 | 237 | 25017 | 4.73e-19 | 0.05 | 0.01 | 5.2 |
117 | Level5 | GO:0007005 | mitochondrion organization and biogenesis | 37 | 989 | 125 | 25129 | 1.81e-18 | 0.04 | 0.00 | 7.3 |
118 | Level5 | GO:0006520 | amino acid metabolic process | 56 | 970 | 312 | 24942 | 2.35e-18 | 0.05 | 0.01 | 4.4 |
119 | Level4 | GO:0006800 | oxygen and reactive oxygen species metabolic process | 26 | 1000 | 49 | 25205 | 2.86e-18 | 0.03 | 0.00 | 13.1 |
120 | Level4 | GO:0009725 | response to hormone stimulus | 36 | 990 | 120 | 25134 | 3.66e-18 | 0.04 | 0.00 | 7.4 |
121 | Level5 | GO:0015980 | energy derivation by oxidation of organic compounds | 38 | 988 | 138 | 25116 | 4.84e-18 | 0.04 | 0.01 | 6.8 |
122 | Level5 | GO:0009892 | negative regulation of metabolic process | 75 | 951 | 551 | 24703 | 5.59e-18 | 0.07 | 0.02 | 3.4 |
123 | Level2 | GO:0040007 | growth | 60 | 966 | 366 | 24888 | 6.47e-18 | 0.06 | 0.01 | 4.0 |
124 | Level3 | GO:0046903 | secretion | 59 | 967 | 356 | 24898 | 7.84e-18 | 0.06 | 0.01 | 4.1 |
125 | Level5 | GO:0007517 | muscle development | 49 | 977 | 254 | 25000 | 2.56e-17 | 0.05 | 0.01 | 4.7 |
126 | Level3 | GO:0001816 | cytokine production | 39 | 987 | 160 | 25094 | 6.00e-17 | 0.04 | 0.01 | 6.0 |
127 | Level4 | GO:0032943 | mononuclear cell proliferation | 29 | 997 | 79 | 25175 | 8.48e-17 | 0.03 | 0.00 | 9.0 |
128 | Level5 | GO:0009889 | regulation of biosynthetic process | 49 | 977 | 264 | 24990 | 9.95e-17 | 0.05 | 0.01 | 4.6 |
129 | Level4 | GO:0006139 | nucleobase\, nucleoside\, nucleotide and nucleic acid metabolic process | 275 | 751 | 4119 | 21135 | 9.98e-17 | 0.27 | 0.16 | 1.6 |
130 | Level2 | GO:0051704 | multi\-organism process | 63 | 963 | 431 | 24823 | 1.36e-16 | 0.06 | 0.02 | 3.6 |
131 | Level3 | GO:0007049 | cell cycle | 95 | 931 | 879 | 24375 | 1.98e-16 | 0.09 | 0.03 | 2.7 |
132 | Level5 | GO:0007268 | synaptic transmission | 59 | 967 | 390 | 24864 | 3.24e-16 | 0.06 | 0.02 | 3.7 |
133 | Level5 | GO:0006461 | protein complex assembly | 60 | 966 | 409 | 24845 | 6.35e-16 | 0.06 | 0.02 | 3.6 |
134 | Level4 | GO:0010033 | response to organic substance | 31 | 995 | 106 | 25148 | 1.41e-15 | 0.03 | 0.00 | 7.2 |
135 | Level2 | GO:0000003 | reproduction | 79 | 947 | 680 | 24574 | 2.27e-15 | 0.08 | 0.03 | 2.9 |
136 | Level5 | GO:0051246 | regulation of protein metabolic process | 57 | 969 | 387 | 24867 | 2.95e-15 | 0.06 | 0.02 | 3.6 |
137 | Level5 | GO:0051241 | negative regulation of multicellular organismal process | 29 | 997 | 94 | 25160 | 3.65e-15 | 0.03 | 0.00 | 7.6 |
138 | Level3 | GO:0022414 | reproductive process | 56 | 970 | 380 | 24874 | 5.08e-15 | 0.05 | 0.02 | 3.6 |
139 | Level4 | GO:0048583 | regulation of response to stimulus | 40 | 986 | 199 | 25055 | 6.75e-15 | 0.04 | 0.01 | 4.9 |
140 | Level5 | GO:0007507 | heart development | 38 | 988 | 179 | 25075 | 7.11e-15 | 0.04 | 0.01 | 5.2 |
141 | Level5 | GO:0051049 | regulation of transport | 40 | 986 | 200 | 25054 | 7.80e-15 | 0.04 | 0.01 | 4.9 |
142 | Level5 | GO:0002521 | leukocyte differentiation | 34 | 992 | 143 | 25111 | 1.11e-14 | 0.03 | 0.01 | 5.9 |
143 | Level5 | GO:0001501 | skeletal development | 48 | 978 | 291 | 24963 | 1.12e-14 | 0.05 | 0.01 | 4.1 |
144 | Level5 | GO:0000302 | response to reactive oxygen species | 20 | 1006 | 36 | 25218 | 1.17e-14 | 0.02 | 0.00 | 13.7 |
145 | Level5 | GO:0003018 | vascular process in circulatory system | 26 | 1000 | 76 | 25178 | 1.31e-14 | 0.03 | 0.00 | 8.4 |
146 | Level5 | GO:0051187 | cofactor catabolic process | 20 | 1006 | 38 | 25216 | 2.55e-14 | 0.02 | 0.00 | 13.0 |
147 | Level5 | GO:0009888 | tissue development | 60 | 966 | 452 | 24802 | 3.48e-14 | 0.06 | 0.02 | 3.3 |
148 | Level4 | GO:0035150 | regulation of tube size | 25 | 1001 | 74 | 25180 | 5.32e-14 | 0.02 | 0.00 | 8.3 |
149 | Level5 | GO:0050880 | regulation of blood vessel size | 25 | 1001 | 74 | 25180 | 5.32e-14 | 0.02 | 0.00 | 8.3 |
150 | Level5 | GO:0030099 | myeloid cell differentiation | 29 | 997 | 107 | 25147 | 6.00e-14 | 0.03 | 0.00 | 6.7 |
151 | Level3 | GO:0048771 | tissue remodeling | 36 | 990 | 175 | 25079 | 8.31e-14 | 0.04 | 0.01 | 5.1 |
152 | Level5 | GO:0048872 | homeostasis of number of cells | 24 | 1002 | 69 | 25185 | 1.01e-13 | 0.02 | 0.00 | 8.6 |
153 | Level4 | GO:0007626 | locomotory behavior | 49 | 977 | 324 | 24930 | 1.11e-13 | 0.05 | 0.01 | 3.7 |
154 | Level4 | GO:0009991 | response to extracellular stimulus | 28 | 998 | 103 | 25151 | 1.53e-13 | 0.03 | 0.00 | 6.7 |
155 | Level5 | GO:0050865 | regulation of cell activation | 29 | 997 | 114 | 25140 | 2.35e-13 | 0.03 | 0.00 | 6.3 |
156 | Level4 | GO:0040008 | regulation of growth | 42 | 984 | 249 | 25005 | 2.70e-13 | 0.04 | 0.01 | 4.2 |
157 | Level4 | GO:0051641 | cellular localization | 107 | 919 | 1198 | 24056 | 3.84e-13 | 0.10 | 0.05 | 2.2 |
158 | Level5 | GO:0046164 | alcohol catabolic process | 28 | 998 | 108 | 25146 | 4.09e-13 | 0.03 | 0.00 | 6.4 |
159 | Level5 | GO:0009310 | amine catabolic process | 26 | 1000 | 91 | 25163 | 4.30e-13 | 0.03 | 0.00 | 7.0 |
160 | Level3 | GO:0009790 | embryonic development | 54 | 972 | 403 | 24851 | 4.88e-13 | 0.05 | 0.02 | 3.3 |
161 | Level5 | GO:0044270 | nitrogen compound catabolic process | 26 | 1000 | 93 | 25161 | 6.54e-13 | 0.03 | 0.00 | 6.9 |
162 | Level4 | GO:0051098 | regulation of binding | 27 | 999 | 102 | 25152 | 7.07e-13 | 0.03 | 0.00 | 6.5 |
163 | Level5 | GO:0031667 | response to nutrient levels | 26 | 1000 | 95 | 25159 | 9.87e-13 | 0.03 | 0.00 | 6.7 |
164 | Level4 | GO:0009057 | macromolecule catabolic process | 60 | 966 | 498 | 24756 | 1.48e-12 | 0.06 | 0.02 | 3.0 |
165 | Level5 | GO:0006801 | superoxide metabolic process | 15 | 1011 | 21 | 25233 | 1.74e-12 | 0.01 | 0.00 | 17.6 |
166 | Level5 | GO:0042330 | taxis | 40 | 986 | 242 | 25012 | 1.76e-12 | 0.04 | 0.01 | 4.1 |
167 | Level3 | GO:0009628 | response to abiotic stimulus | 56 | 970 | 445 | 24809 | 1.77e-12 | 0.05 | 0.02 | 3.1 |
168 | Level5 | GO:0051649 | establishment of cellular localization | 103 | 923 | 1168 | 24086 | 1.97e-12 | 0.10 | 0.05 | 2.2 |
169 | Level4 | GO:0051046 | regulation of secretion | 26 | 1000 | 100 | 25154 | 2.66e-12 | 0.03 | 0.00 | 6.4 |
170 | Level4 | GO:0046849 | bone remodeling | 32 | 994 | 158 | 25096 | 2.86e-12 | 0.03 | 0.01 | 5.0 |
171 | Level5 | GO:0045595 | regulation of cell differentiation | 38 | 988 | 225 | 25029 | 3.57e-12 | 0.04 | 0.01 | 4.2 |
172 | Level4 | GO:0002682 | regulation of immune system process | 36 | 990 | 203 | 25051 | 3.83e-12 | 0.04 | 0.01 | 4.4 |
173 | Level5 | GO:0016053 | organic acid biosynthetic process | 26 | 1000 | 103 | 25151 | 4.70e-12 | 0.03 | 0.00 | 6.2 |
174 | Level4 | GO:0050878 | regulation of body fluid levels | 35 | 991 | 195 | 25059 | 5.65e-12 | 0.03 | 0.01 | 4.4 |
175 | Level5 | GO:0044275 | cellular carbohydrate catabolic process | 29 | 997 | 134 | 25120 | 7.38e-12 | 0.03 | 0.01 | 5.3 |
176 | Level5 | GO:0007010 | cytoskeleton organization and biogenesis | 67 | 959 | 625 | 24629 | 9.68e-12 | 0.07 | 0.02 | 2.6 |
177 | Level5 | GO:0051726 | regulation of cell cycle | 46 | 980 | 333 | 24921 | 1.05e-11 | 0.04 | 0.01 | 3.4 |
178 | Level5 | GO:0015749 | monosaccharide transport | 19 | 1007 | 50 | 25204 | 1.07e-11 | 0.02 | 0.00 | 9.4 |
179 | Level5 | GO:0055086 | nucleobase\, nucleoside and nucleotide metabolic process | 43 | 983 | 297 | 24957 | 1.29e-11 | 0.04 | 0.01 | 3.6 |
180 | Level4 | GO:0050877 | neurological system process | 112 | 914 | 1360 | 23894 | 1.43e-11 | 0.11 | 0.05 | 2.0 |
181 | Level4 | GO:0046209 | nitric oxide metabolic process | 16 | 1010 | 32 | 25222 | 1.81e-11 | 0.02 | 0.00 | 12.3 |
182 | Level5 | GO:0044242 | cellular lipid catabolic process | 24 | 1002 | 93 | 25161 | 2.09e-11 | 0.02 | 0.00 | 6.4 |
183 | Level5 | GO:0016052 | carbohydrate catabolic process | 29 | 997 | 141 | 25113 | 2.16e-11 | 0.03 | 0.01 | 5.1 |
184 | Level5 | GO:0016054 | organic acid catabolic process | 18 | 1008 | 47 | 25207 | 3.37e-11 | 0.02 | 0.00 | 9.4 |
185 | Level3 | GO:0009607 | response to biotic stimulus | 46 | 980 | 347 | 24907 | 3.67e-11 | 0.04 | 0.01 | 3.3 |
186 | Level5 | GO:0042060 | wound healing | 35 | 991 | 212 | 25042 | 4.42e-11 | 0.03 | 0.01 | 4.1 |
187 | Level5 | GO:0046165 | alcohol biosynthetic process | 16 | 1010 | 35 | 25219 | 5.15e-11 | 0.02 | 0.00 | 11.3 |
188 | Level5 | GO:0032101 | regulation of response to external stimulus | 20 | 1006 | 64 | 25190 | 5.65e-11 | 0.02 | 0.00 | 7.7 |
189 | Level5 | GO:0034404 | nucleobase\, nucleoside and nucleotide biosynthetic process | 41 | 985 | 288 | 24966 | 6.14e-11 | 0.04 | 0.01 | 3.5 |
190 | Level4 | GO:0016042 | lipid catabolic process | 33 | 993 | 192 | 25062 | 6.24e-11 | 0.03 | 0.01 | 4.2 |
191 | Level4 | GO:0008217 | regulation of blood pressure | 23 | 1003 | 90 | 25164 | 6.46e-11 | 0.02 | 0.00 | 6.3 |
192 | Level5 | GO:0006259 | DNA metabolic process | 64 | 962 | 611 | 24643 | 6.57e-11 | 0.06 | 0.02 | 2.6 |
193 | Level5 | GO:0048545 | response to steroid hormone stimulus | 20 | 1006 | 65 | 25189 | 7.12e-11 | 0.02 | 0.00 | 7.6 |
194 | Level4 | GO:0022008 | neurogenesis | 51 | 975 | 427 | 24827 | 9.59e-11 | 0.05 | 0.02 | 2.9 |
195 | Level4 | GO:0008610 | lipid biosynthetic process | 44 | 982 | 333 | 24921 | 1.08e-10 | 0.04 | 0.01 | 3.3 |
196 | Level4 | GO:0003012 | muscle system process | 35 | 991 | 221 | 25033 | 1.21e-10 | 0.03 | 0.01 | 3.9 |
197 | Level5 | GO:0006936 | muscle contraction | 35 | 991 | 221 | 25033 | 1.21e-10 | 0.03 | 0.01 | 3.9 |
198 | Level5 | GO:0051270 | regulation of cell motility | 23 | 1003 | 94 | 25160 | 1.35e-10 | 0.02 | 0.00 | 6.0 |
199 | Level4 | GO:0009059 | macromolecule biosynthetic process | 226 | 800 | 3637 | 21617 | 1.39e-10 | 0.22 | 0.14 | 1.5 |
200 | Level5 | GO:0010468 | regulation of gene expression | 191 | 835 | 2926 | 22328 | 1.59e-10 | 0.19 | 0.12 | 1.6 |
201 | Level5 | GO:0030323 | respiratory tube development | 21 | 1005 | 78 | 25176 | 1.93e-10 | 0.02 | 0.00 | 6.6 |
202 | Level5 | GO:0044271 | nitrogen compound biosynthetic process | 26 | 1000 | 127 | 25127 | 2.55e-10 | 0.03 | 0.01 | 5.0 |
203 | Level5 | GO:0007599 | hemostasis | 30 | 996 | 171 | 25083 | 2.98e-10 | 0.03 | 0.01 | 4.3 |
204 | Level5 | GO:0050900 | leukocyte migration | 17 | 1009 | 48 | 25206 | 3.18e-10 | 0.02 | 0.00 | 8.7 |
205 | Level5 | GO:0008202 | steroid metabolic process | 34 | 992 | 218 | 25036 | 3.19e-10 | 0.03 | 0.01 | 3.8 |
206 | Level5 | GO:0042743 | hydrogen peroxide metabolic process | 12 | 1014 | 17 | 25237 | 3.30e-10 | 0.01 | 0.00 | 17.4 |
207 | Level4 | GO:0032844 | regulation of homeostatic process | 14 | 1012 | 28 | 25226 | 3.33e-10 | 0.01 | 0.00 | 12.3 |
208 | Level4 | GO:0022402 | cell cycle process | 56 | 970 | 510 | 24744 | 3.37e-10 | 0.05 | 0.02 | 2.7 |
209 | Level5 | GO:0001763 | morphogenesis of a branching structure | 18 | 1008 | 56 | 25198 | 3.52e-10 | 0.02 | 0.00 | 7.9 |
210 | Level5 | GO:0043086 | negative regulation of catalytic activity | 25 | 1001 | 121 | 25133 | 4.75e-10 | 0.02 | 0.00 | 5.1 |
211 | Level4 | GO:0002250 | adaptive immune response | 28 | 998 | 153 | 25101 | 5.01e-10 | 0.03 | 0.01 | 4.5 |
212 | Level5 | GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 28 | 998 | 153 | 25101 | 5.01e-10 | 0.03 | 0.01 | 4.5 |
213 | Level3 | GO:0002252 | immune effector process | 32 | 994 | 199 | 25055 | 5.37e-10 | 0.03 | 0.01 | 4.0 |
214 | Level5 | GO:0019216 | regulation of lipid metabolic process | 16 | 1010 | 43 | 25211 | 5.87e-10 | 0.02 | 0.00 | 9.2 |
215 | Level3 | GO:0050817 | coagulation | 30 | 996 | 178 | 25076 | 6.94e-10 | 0.03 | 0.01 | 4.1 |
216 | Level5 | GO:0051101 | regulation of DNA binding | 20 | 1006 | 76 | 25178 | 7.30e-10 | 0.02 | 0.00 | 6.5 |
217 | Level5 | GO:0030324 | lung development | 20 | 1006 | 76 | 25178 | 7.30e-10 | 0.02 | 0.00 | 6.5 |
218 | Level3 | GO:0051707 | response to other organism | 36 | 990 | 251 | 25003 | 7.50e-10 | 0.04 | 0.01 | 3.5 |
219 | Level5 | GO:0001817 | regulation of cytokine production | 17 | 1009 | 52 | 25202 | 8.77e-10 | 0.02 | 0.00 | 8.0 |
220 | Level5 | GO:0042107 | cytokine metabolic process | 22 | 1004 | 98 | 25156 | 1.37e-09 | 0.02 | 0.00 | 5.5 |
221 | Level5 | GO:0003001 | generation of a signal involved in cell\-cell signaling | 23 | 1003 | 109 | 25145 | 1.64e-09 | 0.02 | 0.00 | 5.2 |
222 | Level4 | GO:0006725 | aromatic compound metabolic process | 31 | 995 | 199 | 25055 | 1.97e-09 | 0.03 | 0.01 | 3.8 |
223 | Level5 | GO:0042744 | hydrogen peroxide catabolic process | 11 | 1015 | 16 | 25238 | 2.24e-09 | 0.01 | 0.00 | 16.9 |
224 | Level4 | GO:0010035 | response to inorganic substance | 17 | 1009 | 56 | 25198 | 2.24e-09 | 0.02 | 0.00 | 7.5 |
225 | Level5 | GO:0043284 | biopolymer biosynthetic process | 187 | 839 | 2949 | 22305 | 2.27e-09 | 0.18 | 0.12 | 1.6 |
226 | Level4 | GO:0016044 | membrane organization and biogenesis | 43 | 983 | 359 | 24895 | 2.65e-09 | 0.04 | 0.01 | 2.9 |
227 | Level3 | GO:0021700 | developmental maturation | 22 | 1004 | 103 | 25151 | 3.05e-09 | 0.02 | 0.00 | 5.3 |
228 | Level5 | GO:0045765 | regulation of angiogenesis | 16 | 1010 | 50 | 25204 | 3.54e-09 | 0.02 | 0.00 | 7.9 |
229 | Level5 | GO:0002684 | positive regulation of immune system process | 27 | 999 | 159 | 25095 | 4.25e-09 | 0.03 | 0.01 | 4.2 |
230 | Level5 | GO:0006350 | transcription | 182 | 844 | 2872 | 22382 | 4.96e-09 | 0.18 | 0.11 | 1.6 |
231 | Level4 | GO:0031589 | cell\-substrate adhesion | 24 | 1002 | 129 | 25125 | 6.45e-09 | 0.02 | 0.01 | 4.6 |
232 | Level4 | GO:0043062 | extracellular structure organization and biogenesis | 25 | 1001 | 140 | 25114 | 6.51e-09 | 0.02 | 0.01 | 4.4 |
233 | Level5 | GO:0007050 | cell cycle arrest | 21 | 1005 | 98 | 25156 | 6.60e-09 | 0.02 | 0.00 | 5.3 |
234 | Level3 | GO:0035264 | multicellular organism growth | 15 | 1011 | 45 | 25209 | 6.91e-09 | 0.01 | 0.00 | 8.2 |
235 | Level3 | GO:0007565 | female pregnancy | 20 | 1006 | 89 | 25165 | 7.51e-09 | 0.02 | 0.00 | 5.5 |
236 | Level4 | GO:0016337 | cell\-cell adhesion | 43 | 983 | 374 | 24880 | 7.95e-09 | 0.04 | 0.01 | 2.8 |
237 | Level4 | GO:0065003 | macromolecular complex assembly | 70 | 956 | 786 | 24468 | 8.04e-09 | 0.07 | 0.03 | 2.2 |
238 | Level5 | GO:0016051 | carbohydrate biosynthetic process | 26 | 1000 | 153 | 25101 | 8.08e-09 | 0.03 | 0.01 | 4.2 |
239 | Level4 | GO:0001505 | regulation of neurotransmitter levels | 22 | 1004 | 111 | 25143 | 1.01e-08 | 0.02 | 0.00 | 4.9 |
240 | Level5 | GO:0031347 | regulation of defense response | 18 | 1008 | 72 | 25182 | 1.02e-08 | 0.02 | 0.00 | 6.2 |
241 | Level5 | GO:0010038 | response to metal ion | 15 | 1011 | 47 | 25207 | 1.12e-08 | 0.01 | 0.00 | 7.9 |
242 | Level5 | GO:0051240 | positive regulation of multicellular organismal process | 20 | 1006 | 92 | 25162 | 1.22e-08 | 0.02 | 0.00 | 5.4 |
243 | Level5 | GO:0046883 | regulation of hormone secretion | 14 | 1012 | 40 | 25214 | 1.32e-08 | 0.01 | 0.00 | 8.6 |
244 | Level4 | GO:0033002 | muscle cell proliferation | 13 | 1013 | 33 | 25221 | 1.39e-08 | 0.01 | 0.00 | 9.7 |
245 | Level5 | GO:0048584 | positive regulation of response to stimulus | 24 | 1002 | 136 | 25118 | 1.59e-08 | 0.02 | 0.01 | 4.3 |
246 | Level5 | GO:0016125 | sterol metabolic process | 21 | 1005 | 105 | 25149 | 1.89e-08 | 0.02 | 0.00 | 4.9 |
247 | Level4 | GO:0008643 | carbohydrate transport | 19 | 1007 | 85 | 25169 | 1.91e-08 | 0.02 | 0.00 | 5.5 |
248 | Level5 | GO:0048699 | generation of neurons | 44 | 982 | 403 | 24851 | 2.15e-08 | 0.04 | 0.02 | 2.7 |
249 | Level4 | GO:0000278 | mitotic cell cycle | 43 | 983 | 390 | 24864 | 2.40e-08 | 0.04 | 0.02 | 2.7 |
250 | Level5 | GO:0003015 | heart process | 19 | 1007 | 87 | 25167 | 2.64e-08 | 0.02 | 0.00 | 5.4 |
251 | Level4 | GO:0015833 | peptide transport | 15 | 1011 | 51 | 25203 | 2.80e-08 | 0.01 | 0.00 | 7.2 |
252 | Level4 | GO:0002790 | peptide secretion | 13 | 1013 | 36 | 25218 | 3.23e-08 | 0.01 | 0.00 | 8.9 |
253 | Level4 | GO:0050673 | epithelial cell proliferation | 15 | 1011 | 52 | 25202 | 3.48e-08 | 0.01 | 0.00 | 7.1 |
254 | Level5 | GO:0051235 | maintenance of localization | 15 | 1011 | 52 | 25202 | 3.48e-08 | 0.01 | 0.00 | 7.1 |
255 | Level4 | GO:0006790 | sulfur metabolic process | 20 | 1006 | 100 | 25154 | 4.10e-08 | 0.02 | 0.00 | 4.9 |
256 | Level3 | GO:0051716 | cellular response to stimulus | 13 | 1013 | 37 | 25217 | 4.21e-08 | 0.01 | 0.00 | 8.6 |
257 | Level5 | GO:0030198 | extracellular matrix organization and biogenesis | 17 | 1009 | 72 | 25182 | 5.35e-08 | 0.02 | 0.00 | 5.8 |
258 | Level5 | GO:0007160 | cell\-matrix adhesion | 22 | 1004 | 124 | 25130 | 5.75e-08 | 0.02 | 0.00 | 4.4 |
259 | Level5 | GO:0040014 | regulation of multicellular organism growth | 13 | 1013 | 39 | 25215 | 7.00e-08 | 0.01 | 0.00 | 8.2 |
260 | Level5 | GO:0017038 | protein import | 23 | 1003 | 137 | 25117 | 7.07e-08 | 0.02 | 0.01 | 4.1 |
261 | Level3 | GO:0045165 | cell fate commitment | 21 | 1005 | 115 | 25139 | 7.44e-08 | 0.02 | 0.00 | 4.5 |
262 | Level3 | GO:0007586 | digestion | 22 | 1004 | 127 | 25127 | 8.34e-08 | 0.02 | 0.01 | 4.3 |
263 | Level4 | GO:0002443 | leukocyte mediated immunity | 24 | 1002 | 152 | 25102 | 1.03e-07 | 0.02 | 0.01 | 3.9 |
264 | Level5 | GO:0048585 | negative regulation of response to stimulus | 13 | 1013 | 41 | 25213 | 1.14e-07 | 0.01 | 0.00 | 7.8 |
265 | Level5 | GO:0001655 | urogenital system development | 16 | 1010 | 67 | 25187 | 1.15e-07 | 0.02 | 0.00 | 5.9 |
266 | Level5 | GO:0001822 | kidney development | 15 | 1011 | 59 | 25195 | 1.42e-07 | 0.01 | 0.00 | 6.3 |
267 | Level4 | GO:0032602 | chemokine production | 9 | 1017 | 15 | 25239 | 1.57e-07 | 0.01 | 0.00 | 14.8 |
268 | Level5 | GO:0043009 | chordate embryonic development | 26 | 1000 | 181 | 25073 | 1.64e-07 | 0.03 | 0.01 | 3.5 |
269 | Level3 | GO:0003006 | reproductive developmental process | 21 | 1005 | 122 | 25132 | 1.79e-07 | 0.02 | 0.00 | 4.2 |
270 | Level4 | GO:0009792 | embryonic development ending in birth or egg hatching | 26 | 1000 | 182 | 25072 | 1.80e-07 | 0.03 | 0.01 | 3.5 |
271 | Level5 | GO:0045927 | positive regulation of growth | 12 | 1014 | 36 | 25218 | 2.23e-07 | 0.01 | 0.00 | 8.2 |
272 | Level5 | GO:0051047 | positive regulation of secretion | 13 | 1013 | 44 | 25210 | 2.25e-07 | 0.01 | 0.00 | 7.3 |
273 | Level5 | GO:0042692 | muscle cell differentiation | 17 | 1009 | 81 | 25173 | 2.32e-07 | 0.02 | 0.00 | 5.2 |
274 | Level5 | GO:0048659 | smooth muscle cell proliferation | 10 | 1016 | 22 | 25232 | 2.32e-07 | 0.01 | 0.00 | 11.2 |
275 | Level4 | GO:0008361 | regulation of cell size | 29 | 997 | 227 | 25027 | 3.04e-07 | 0.03 | 0.01 | 3.1 |
276 | Level3 | GO:0010467 | gene expression | 217 | 809 | 3792 | 21462 | 3.19e-07 | 0.21 | 0.15 | 1.4 |
277 | Level5 | GO:0002274 | myeloid leukocyte activation | 11 | 1015 | 30 | 25224 | 3.28e-07 | 0.01 | 0.00 | 9.0 |
278 | Level5 | GO:0002009 | morphogenesis of an epithelium | 20 | 1006 | 116 | 25138 | 3.42e-07 | 0.02 | 0.00 | 4.2 |
279 | Level4 | GO:0002440 | production of molecular mediator of immune response | 13 | 1013 | 46 | 25208 | 3.46e-07 | 0.01 | 0.00 | 7.0 |
280 | Level4 | GO:0009314 | response to radiation | 23 | 1003 | 153 | 25101 | 4.10e-07 | 0.02 | 0.01 | 3.7 |
281 | Level5 | GO:0034103 | regulation of tissue remodeling | 12 | 1014 | 39 | 25215 | 4.57e-07 | 0.01 | 0.00 | 7.6 |
282 | Level5 | GO:0051336 | regulation of hydrolase activity | 30 | 996 | 246 | 25008 | 4.67e-07 | 0.03 | 0.01 | 3.0 |
283 | Level5 | GO:0016049 | cell growth | 28 | 998 | 219 | 25035 | 4.77e-07 | 0.03 | 0.01 | 3.1 |
284 | Level4 | GO:0048747 | muscle fiber development | 17 | 1009 | 86 | 25168 | 4.85e-07 | 0.02 | 0.00 | 4.9 |
285 | Level4 | GO:0048469 | cell maturation | 17 | 1009 | 86 | 25168 | 4.85e-07 | 0.02 | 0.00 | 4.9 |
286 | Level5 | GO:0048741 | skeletal muscle fiber development | 17 | 1009 | 86 | 25168 | 4.85e-07 | 0.02 | 0.00 | 4.9 |
287 | Level4 | GO:0030155 | regulation of cell adhesion | 18 | 1008 | 97 | 25157 | 5.10e-07 | 0.02 | 0.00 | 4.6 |
288 | Level3 | GO:0006974 | response to DNA damage stimulus | 39 | 987 | 383 | 24871 | 7.25e-07 | 0.04 | 0.02 | 2.5 |
289 | Level5 | GO:0051051 | negative regulation of transport | 13 | 1013 | 51 | 25203 | 9.38e-07 | 0.01 | 0.00 | 6.3 |
290 | Level5 | GO:0007417 | central nervous system development | 36 | 990 | 336 | 24918 | 9.43e-07 | 0.04 | 0.01 | 2.6 |
291 | Level5 | GO:0022403 | cell cycle phase | 41 | 985 | 418 | 24836 | 1.06e-06 | 0.04 | 0.02 | 2.4 |
292 | Level5 | GO:0002377 | immunoglobulin production | 11 | 1015 | 35 | 25219 | 1.16e-06 | 0.01 | 0.00 | 7.7 |
293 | Level5 | GO:0002526 | acute inflammatory response | 21 | 1005 | 139 | 25115 | 1.20e-06 | 0.02 | 0.01 | 3.7 |
294 | Level4 | GO:0042493 | response to drug | 18 | 1008 | 104 | 25150 | 1.24e-06 | 0.02 | 0.00 | 4.3 |
295 | Level5 | GO:0042133 | neurotransmitter metabolic process | 12 | 1014 | 44 | 25210 | 1.34e-06 | 0.01 | 0.00 | 6.7 |
296 | Level4 | GO:0021915 | neural tube development | 12 | 1014 | 45 | 25209 | 1.64e-06 | 0.01 | 0.00 | 6.6 |
297 | Level5 | GO:0002449 | lymphocyte mediated immunity | 21 | 1005 | 144 | 25110 | 1.99e-06 | 0.02 | 0.01 | 3.6 |
298 | Level4 | GO:0006662 | glycerol ether metabolic process | 11 | 1015 | 38 | 25216 | 2.27e-06 | 0.01 | 0.00 | 7.1 |
299 | Level4 | GO:0044243 | multicellular organismal catabolic process | 10 | 1016 | 30 | 25224 | 2.30e-06 | 0.01 | 0.00 | 8.2 |
300 | Level4 | GO:0006811 | ion transport | 80 | 946 | 1107 | 24147 | 2.32e-06 | 0.08 | 0.04 | 1.8 |
301 | Level5 | GO:0043542 | endothelial cell migration | 9 | 1017 | 23 | 25231 | 2.54e-06 | 0.01 | 0.00 | 9.6 |
302 | Level5 | GO:0019439 | aromatic compound catabolic process | 9 | 1017 | 23 | 25231 | 2.54e-06 | 0.01 | 0.00 | 9.6 |
303 | Level4 | GO:0007631 | feeding behavior | 13 | 1013 | 57 | 25197 | 2.73e-06 | 0.01 | 0.00 | 5.6 |
304 | Level5 | GO:0051050 | positive regulation of transport | 14 | 1012 | 67 | 25187 | 2.78e-06 | 0.01 | 0.00 | 5.1 |
305 | Level4 | GO:0009617 | response to bacterium | 20 | 1006 | 135 | 25119 | 2.80e-06 | 0.02 | 0.01 | 3.6 |
306 | Level5 | GO:0002237 | response to molecule of bacterial origin | 8 | 1018 | 17 | 25237 | 3.14e-06 | 0.01 | 0.00 | 11.6 |
307 | Level5 | GO:0050776 | regulation of immune response | 19 | 1007 | 124 | 25130 | 3.18e-06 | 0.02 | 0.00 | 3.8 |
308 | Level4 | GO:0014031 | mesenchymal cell development | 11 | 1015 | 40 | 25214 | 3.46e-06 | 0.01 | 0.00 | 6.8 |
309 | Level5 | GO:0048762 | mesenchymal cell differentiation | 11 | 1015 | 40 | 25214 | 3.46e-06 | 0.01 | 0.00 | 6.8 |
310 | Level5 | GO:0002683 | negative regulation of immune system process | 12 | 1014 | 49 | 25205 | 3.50e-06 | 0.01 | 0.00 | 6.0 |
311 | Level5 | GO:0048598 | embryonic morphogenesis | 23 | 1003 | 176 | 25078 | 3.54e-06 | 0.02 | 0.01 | 3.2 |
312 | Level4 | GO:0007548 | sex differentiation | 18 | 1008 | 114 | 25140 | 3.95e-06 | 0.02 | 0.00 | 3.9 |
313 | Level5 | GO:0050708 | regulation of protein secretion | 11 | 1015 | 41 | 25213 | 4.23e-06 | 0.01 | 0.00 | 6.6 |
314 | Level4 | GO:0042445 | hormone metabolic process | 17 | 1009 | 103 | 25151 | 4.30e-06 | 0.02 | 0.00 | 4.1 |
315 | Level5 | GO:0051171 | regulation of nitrogen compound metabolic process | 9 | 1017 | 25 | 25229 | 4.42e-06 | 0.01 | 0.00 | 8.9 |
316 | Level4 | GO:0043112 | receptor metabolic process | 10 | 1016 | 33 | 25221 | 4.67e-06 | 0.01 | 0.00 | 7.5 |
317 | Level5 | GO:0051188 | cofactor biosynthetic process | 19 | 1007 | 128 | 25126 | 4.81e-06 | 0.02 | 0.01 | 3.7 |
318 | Level4 | GO:0046483 | heterocycle metabolic process | 17 | 1009 | 104 | 25150 | 4.83e-06 | 0.02 | 0.00 | 4.0 |
319 | Level5 | GO:0009416 | response to light stimulus | 18 | 1008 | 116 | 25138 | 4.90e-06 | 0.02 | 0.00 | 3.8 |
320 | Level5 | GO:0007423 | sensory organ development | 20 | 1006 | 141 | 25113 | 5.05e-06 | 0.02 | 0.01 | 3.5 |
321 | Level5 | GO:0051099 | positive regulation of binding | 11 | 1015 | 42 | 25212 | 5.15e-06 | 0.01 | 0.00 | 6.4 |
322 | Level3 | GO:0044236 | multicellular organismal metabolic process | 10 | 1016 | 34 | 25220 | 5.83e-06 | 0.01 | 0.00 | 7.2 |
323 | Level5 | GO:0048871 | multicellular organismal homeostasis | 10 | 1016 | 34 | 25220 | 5.83e-06 | 0.01 | 0.00 | 7.2 |
324 | Level4 | GO:0032615 | interleukin\-12 production | 7 | 1019 | 13 | 25241 | 6.72e-06 | 0.01 | 0.00 | 13.3 |
325 | Level5 | GO:0006638 | neutral lipid metabolic process | 10 | 1016 | 35 | 25219 | 7.23e-06 | 0.01 | 0.00 | 7.0 |
326 | Level4 | GO:0044259 | multicellular organismal macromolecule metabolic process | 9 | 1017 | 27 | 25227 | 7.39e-06 | 0.01 | 0.00 | 8.2 |
327 | Level4 | GO:0044256 | protein digestion | 9 | 1017 | 27 | 25227 | 7.39e-06 | 0.01 | 0.00 | 8.2 |
328 | Level5 | GO:0044266 | multicellular organismal macromolecule catabolic process | 9 | 1017 | 27 | 25227 | 7.39e-06 | 0.01 | 0.00 | 8.2 |
329 | Level5 | GO:0044268 | multicellular organismal protein metabolic process | 9 | 1017 | 27 | 25227 | 7.39e-06 | 0.01 | 0.00 | 8.2 |
330 | Level5 | GO:0042558 | pteridine and derivative metabolic process | 8 | 1018 | 20 | 25234 | 8.13e-06 | 0.01 | 0.00 | 9.8 |
331 | Level5 | GO:0016070 | RNA metabolic process | 183 | 843 | 3241 | 22013 | 8.16e-06 | 0.18 | 0.13 | 1.4 |
332 | Level5 | GO:0008016 | regulation of heart contraction | 14 | 1012 | 75 | 25179 | 8.72e-06 | 0.01 | 0.00 | 4.6 |
333 | Level5 | GO:0050818 | regulation of coagulation | 10 | 1016 | 36 | 25218 | 8.92e-06 | 0.01 | 0.00 | 6.8 |
334 | Level5 | GO:0001558 | regulation of cell growth | 22 | 1004 | 176 | 25078 | 1.08e-05 | 0.02 | 0.01 | 3.1 |
335 | Level4 | GO:0033554 | cellular response to stress | 8 | 1018 | 21 | 25233 | 1.08e-05 | 0.01 | 0.00 | 9.4 |
336 | Level5 | GO:0043434 | response to peptide hormone stimulus | 10 | 1016 | 37 | 25217 | 1.09e-05 | 0.01 | 0.00 | 6.7 |
337 | Level5 | GO:0046486 | glycerolipid metabolic process | 10 | 1016 | 37 | 25217 | 1.09e-05 | 0.01 | 0.00 | 6.7 |
338 | Level3 | GO:0032504 | multicellular organism reproduction | 15 | 1011 | 88 | 25166 | 1.11e-05 | 0.01 | 0.00 | 4.2 |
339 | Level4 | GO:0048609 | reproductive process in a multicellular organism | 15 | 1011 | 88 | 25166 | 1.11e-05 | 0.01 | 0.00 | 4.2 |
340 | Level5 | GO:0031644 | regulation of neurological system process | 14 | 1012 | 77 | 25177 | 1.14e-05 | 0.01 | 0.00 | 4.5 |
341 | Level5 | GO:0032963 | collagen metabolic process | 9 | 1017 | 29 | 25225 | 1.19e-05 | 0.01 | 0.00 | 7.6 |
342 | Level5 | GO:0008354 | germ cell migration | 6 | 1020 | 9 | 25245 | 1.29e-05 | 0.01 | 0.00 | 16.4 |
343 | Level5 | GO:0044265 | cellular macromolecule catabolic process | 37 | 989 | 397 | 24857 | 1.33e-05 | 0.04 | 0.02 | 2.3 |
344 | Level5 | GO:0006575 | amino acid derivative metabolic process | 16 | 1010 | 102 | 25152 | 1.44e-05 | 0.02 | 0.00 | 3.9 |
345 | Level4 | GO:0007584 | response to nutrient | 13 | 1013 | 69 | 25185 | 1.66e-05 | 0.01 | 0.00 | 4.6 |
346 | Level4 | GO:0007389 | pattern specification process | 24 | 1002 | 211 | 25043 | 1.83e-05 | 0.02 | 0.01 | 2.8 |
347 | Level5 | GO:0051048 | negative regulation of secretion | 9 | 1017 | 31 | 25223 | 1.87e-05 | 0.01 | 0.00 | 7.1 |
348 | Level5 | GO:0009894 | regulation of catabolic process | 10 | 1016 | 40 | 25214 | 1.95e-05 | 0.01 | 0.00 | 6.2 |
349 | Level5 | GO:0045926 | negative regulation of growth | 14 | 1012 | 82 | 25172 | 2.12e-05 | 0.01 | 0.00 | 4.2 |
350 | Level5 | GO:0030278 | regulation of ossification | 9 | 1017 | 32 | 25222 | 2.31e-05 | 0.01 | 0.00 | 6.9 |
351 | Level5 | GO:0006767 | water\-soluble vitamin metabolic process | 11 | 1015 | 51 | 25203 | 2.49e-05 | 0.01 | 0.00 | 5.3 |
352 | Level5 | GO:0051341 | regulation of oxidoreductase activity | 7 | 1019 | 17 | 25237 | 2.62e-05 | 0.01 | 0.00 | 10.1 |
353 | Level4 | GO:0008104 | protein localization | 71 | 955 | 1019 | 24235 | 2.81e-05 | 0.07 | 0.04 | 1.7 |
354 | Level5 | GO:0051128 | regulation of cellular component organization and biogenesis | 32 | 994 | 336 | 24918 | 2.91e-05 | 0.03 | 0.01 | 2.3 |
355 | Level5 | GO:0007595 | lactation | 8 | 1018 | 25 | 25229 | 3.05e-05 | 0.01 | 0.00 | 7.9 |
356 | Level4 | GO:0006968 | cellular defense response | 15 | 1011 | 97 | 25157 | 3.07e-05 | 0.01 | 0.00 | 3.8 |
357 | Level5 | GO:0051283 | negative regulation of sequestering of calcium ion | 5 | 1021 | 6 | 25248 | 3.41e-05 | 0.00 | 0.00 | 20.5 |
358 | Level4 | GO:0007281 | germ cell development | 9 | 1017 | 34 | 25220 | 3.47e-05 | 0.01 | 0.00 | 6.5 |
359 | Level5 | GO:0051591 | response to cAMP | 7 | 1019 | 18 | 25236 | 3.51e-05 | 0.01 | 0.00 | 9.6 |
360 | Level5 | GO:0045792 | negative regulation of cell size | 12 | 1014 | 65 | 25189 | 4.16e-05 | 0.01 | 0.00 | 4.5 |
361 | Level3 | GO:0007568 | aging | 9 | 1017 | 35 | 25219 | 4.21e-05 | 0.01 | 0.00 | 6.3 |
362 | Level4 | GO:0006766 | vitamin metabolic process | 13 | 1013 | 77 | 25177 | 4.60e-05 | 0.01 | 0.00 | 4.2 |
363 | Level4 | GO:0031668 | cellular response to extracellular stimulus | 7 | 1019 | 19 | 25235 | 4.64e-05 | 0.01 | 0.00 | 9.1 |
364 | Level4 | GO:0048144 | fibroblast proliferation | 7 | 1019 | 19 | 25235 | 4.64e-05 | 0.01 | 0.00 | 9.1 |
365 | Level5 | GO:0019229 | regulation of vasoconstriction | 7 | 1019 | 19 | 25235 | 4.64e-05 | 0.01 | 0.00 | 9.1 |
366 | Level5 | GO:0006109 | regulation of carbohydrate metabolic process | 7 | 1019 | 19 | 25235 | 4.64e-05 | 0.01 | 0.00 | 9.1 |
367 | Level5 | GO:0019438 | aromatic compound biosynthetic process | 7 | 1019 | 19 | 25235 | 4.64e-05 | 0.01 | 0.00 | 9.1 |
368 | Level5 | GO:0015992 | proton transport | 15 | 1011 | 101 | 25153 | 4.66e-05 | 0.01 | 0.00 | 3.7 |
369 | Level4 | GO:0045137 | development of primary sexual characteristics | 14 | 1012 | 89 | 25165 | 4.74e-05 | 0.01 | 0.00 | 3.9 |
370 | Level5 | GO:0014032 | neural crest cell development | 8 | 1018 | 27 | 25227 | 4.83e-05 | 0.01 | 0.00 | 7.3 |
371 | Level5 | GO:0015918 | sterol transport | 8 | 1018 | 27 | 25227 | 4.83e-05 | 0.01 | 0.00 | 7.3 |
372 | Level4 | GO:0006818 | hydrogen transport | 15 | 1011 | 103 | 25151 | 5.70e-05 | 0.01 | 0.00 | 3.6 |
373 | Level3 | GO:0019953 | sexual reproduction | 36 | 990 | 412 | 24842 | 5.83e-05 | 0.04 | 0.02 | 2.2 |
374 | Level3 | GO:0033036 | macromolecule localization | 72 | 954 | 1067 | 24187 | 5.98e-05 | 0.07 | 0.04 | 1.7 |
375 | Level3 | GO:0007585 | respiratory gaseous exchange | 9 | 1017 | 37 | 25217 | 6.10e-05 | 0.01 | 0.00 | 6.0 |
376 | Level4 | GO:0032989 | cellular structure morphogenesis | 36 | 990 | 415 | 24839 | 6.23e-05 | 0.04 | 0.02 | 2.1 |
377 | Level5 | GO:0000902 | cell morphogenesis | 36 | 990 | 415 | 24839 | 6.23e-05 | 0.04 | 0.02 | 2.1 |
378 | Level5 | GO:0010564 | regulation of cell cycle process | 12 | 1014 | 70 | 25184 | 7.85e-05 | 0.01 | 0.00 | 4.2 |
379 | Level4 | GO:0007588 | excretion | 11 | 1015 | 59 | 25195 | 7.98e-05 | 0.01 | 0.00 | 4.6 |
380 | Level5 | GO:0007420 | brain development | 23 | 1003 | 219 | 25035 | 8.31e-05 | 0.02 | 0.01 | 2.6 |
381 | Level5 | GO:0032990 | cell part morphogenesis | 30 | 996 | 327 | 24927 | 8.56e-05 | 0.03 | 0.01 | 2.3 |
382 | Level4 | GO:0034330 | cell junction assembly and maintenance | 8 | 1018 | 30 | 25224 | 9.04e-05 | 0.01 | 0.00 | 6.6 |
383 | Level3 | GO:0045184 | establishment of protein localization | 65 | 961 | 951 | 24303 | 9.45e-05 | 0.06 | 0.04 | 1.7 |
384 | Level5 | GO:0009743 | response to carbohydrate stimulus | 7 | 1019 | 22 | 25232 | 9.94e-05 | 0.01 | 0.00 | 7.8 |
385 | Level5 | GO:0007006 | mitochondrial membrane organization and biogenesis | 7 | 1019 | 22 | 25232 | 9.94e-05 | 0.01 | 0.00 | 7.8 |
386 | Level5 | GO:0034329 | cell junction assembly | 7 | 1019 | 22 | 25232 | 9.94e-05 | 0.01 | 0.00 | 7.8 |
387 | Level5 | GO:0042446 | hormone biosynthetic process | 10 | 1016 | 50 | 25204 | 1.01e-04 | 0.01 | 0.00 | 4.9 |
388 | Level5 | GO:0006812 | cation transport | 55 | 971 | 765 | 24489 | 1.04e-04 | 0.05 | 0.03 | 1.8 |
389 | Level4 | GO:0009636 | response to toxin | 8 | 1018 | 31 | 25223 | 1.10e-04 | 0.01 | 0.00 | 6.4 |
390 | Level5 | GO:0019751 | polyol metabolic process | 10 | 1016 | 51 | 25203 | 1.16e-04 | 0.01 | 0.00 | 4.8 |
391 | Level5 | GO:0030503 | regulation of cell redox homeostasis | 5 | 1021 | 9 | 25245 | 1.34e-04 | 0.00 | 0.00 | 13.7 |
392 | Level2 | GO:0043473 | pigmentation | 9 | 1017 | 42 | 25212 | 1.41e-04 | 0.01 | 0.00 | 5.3 |
393 | Level5 | GO:0032800 | receptor biosynthetic process | 4 | 1022 | 4 | 25250 | 1.42e-04 | 0.00 | 0.00 | 24.6 |
394 | Level5 | GO:0010324 | membrane invagination | 24 | 1002 | 241 | 25013 | 1.50e-04 | 0.02 | 0.01 | 2.5 |
395 | Level5 | GO:0007159 | leukocyte adhesion | 6 | 1020 | 16 | 25238 | 1.52e-04 | 0.01 | 0.00 | 9.2 |
396 | Level5 | GO:0055002 | striated muscle cell development | 6 | 1020 | 16 | 25238 | 1.52e-04 | 0.01 | 0.00 | 9.2 |
397 | Level4 | GO:0042440 | pigment metabolic process | 10 | 1016 | 53 | 25201 | 1.53e-04 | 0.01 | 0.00 | 4.6 |
398 | Level4 | GO:0009620 | response to fungus | 7 | 1019 | 24 | 25230 | 1.57e-04 | 0.01 | 0.00 | 7.2 |
399 | Level5 | GO:0043285 | biopolymer catabolic process | 33 | 993 | 383 | 24871 | 1.60e-04 | 0.03 | 0.02 | 2.1 |
400 | Level3 | GO:0019748 | secondary metabolic process | 11 | 1015 | 65 | 25189 | 1.71e-04 | 0.01 | 0.00 | 4.2 |
401 | Level5 | GO:0051969 | regulation of transmission of nerve impulse | 11 | 1015 | 65 | 25189 | 1.71e-04 | 0.01 | 0.00 | 4.2 |
402 | Level5 | GO:0048568 | embryonic organ development | 8 | 1018 | 34 | 25220 | 1.90e-04 | 0.01 | 0.00 | 5.8 |
403 | Level4 | GO:0032635 | interleukin\-6 production | 7 | 1019 | 25 | 25229 | 1.94e-04 | 0.01 | 0.00 | 6.9 |
404 | Level4 | GO:0003014 | renal system process | 6 | 1020 | 17 | 25237 | 1.99e-04 | 0.01 | 0.00 | 8.7 |
405 | Level4 | GO:0055001 | muscle cell development | 6 | 1020 | 17 | 25237 | 1.99e-04 | 0.01 | 0.00 | 8.7 |
406 | Level5 | GO:0008406 | gonad development | 12 | 1014 | 79 | 25175 | 2.17e-04 | 0.01 | 0.00 | 3.7 |
407 | Level5 | GO:0006937 | regulation of muscle contraction | 10 | 1016 | 56 | 25198 | 2.28e-04 | 0.01 | 0.00 | 4.4 |
408 | Level5 | GO:0007033 | vacuole organization and biogenesis | 7 | 1019 | 26 | 25228 | 2.37e-04 | 0.01 | 0.00 | 6.6 |
409 | Level4 | GO:0009266 | response to temperature stimulus | 23 | 1003 | 234 | 25020 | 2.38e-04 | 0.02 | 0.01 | 2.4 |
410 | Level4 | GO:0048608 | reproductive structure development | 12 | 1014 | 81 | 25173 | 2.67e-04 | 0.01 | 0.00 | 3.6 |
411 | Level5 | GO:0007369 | gastrulation | 9 | 1017 | 47 | 25207 | 2.96e-04 | 0.01 | 0.00 | 4.7 |
412 | Level4 | GO:0009615 | response to virus | 15 | 1011 | 122 | 25132 | 3.08e-04 | 0.01 | 0.00 | 3.0 |
413 | Level5 | GO:0042551 | neuron maturation | 6 | 1020 | 19 | 25235 | 3.26e-04 | 0.01 | 0.00 | 7.8 |
414 | Level5 | GO:0048565 | gut development | 6 | 1020 | 19 | 25235 | 3.26e-04 | 0.01 | 0.00 | 7.8 |
415 | Level3 | GO:0030534 | adult behavior | 10 | 1016 | 59 | 25195 | 3.31e-04 | 0.01 | 0.00 | 4.2 |
416 | Level3 | GO:0048066 | pigmentation during development | 7 | 1019 | 28 | 25226 | 3.49e-04 | 0.01 | 0.00 | 6.2 |
417 | Level5 | GO:0019915 | sequestering of lipid | 5 | 1021 | 12 | 25242 | 3.75e-04 | 0.00 | 0.00 | 10.3 |
418 | Level5 | GO:0050767 | regulation of neurogenesis | 11 | 1015 | 72 | 25182 | 3.76e-04 | 0.01 | 0.00 | 3.8 |
419 | Level3 | GO:0019882 | antigen processing and presentation | 12 | 1014 | 85 | 25169 | 3.96e-04 | 0.01 | 0.00 | 3.5 |
420 | Level4 | GO:0032098 | regulation of appetite | 4 | 1022 | 6 | 25248 | 4.02e-04 | 0.00 | 0.00 | 16.4 |
421 | Level4 | GO:0046902 | regulation of mitochondrial membrane permeability | 4 | 1022 | 6 | 25248 | 4.02e-04 | 0.00 | 0.00 | 16.4 |
422 | Level3 | GO:0051301 | cell division | 25 | 1001 | 276 | 24978 | 4.25e-04 | 0.02 | 0.01 | 2.2 |
423 | Level5 | GO:0006308 | DNA catabolic process | 8 | 1018 | 39 | 25215 | 4.26e-04 | 0.01 | 0.00 | 5.0 |
424 | Level5 | GO:0032880 | regulation of protein localization | 8 | 1018 | 39 | 25215 | 4.26e-04 | 0.01 | 0.00 | 5.0 |
425 | Level4 | GO:0046661 | male sex differentiation | 9 | 1017 | 50 | 25204 | 4.42e-04 | 0.01 | 0.00 | 4.4 |
426 | Level3 | GO:0048589 | developmental growth | 10 | 1016 | 62 | 25192 | 4.69e-04 | 0.01 | 0.00 | 4.0 |
427 | Level5 | GO:0051100 | negative regulation of binding | 7 | 1019 | 30 | 25224 | 5.00e-04 | 0.01 | 0.00 | 5.7 |
428 | Level5 | GO:0001843 | neural tube closure | 7 | 1019 | 30 | 25224 | 5.00e-04 | 0.01 | 0.00 | 5.7 |
429 | Level5 | GO:0030855 | epithelial cell differentiation | 9 | 1017 | 51 | 25203 | 5.02e-04 | 0.01 | 0.00 | 4.3 |
430 | Level4 | GO:0050886 | endocrine process | 5 | 1021 | 13 | 25241 | 5.03e-04 | 0.00 | 0.00 | 9.5 |
431 | Level4 | GO:0050803 | regulation of synapse structure and activity | 5 | 1021 | 13 | 25241 | 5.03e-04 | 0.00 | 0.00 | 9.5 |
432 | Level5 | GO:0050795 | regulation of behavior | 6 | 1020 | 21 | 25233 | 5.10e-04 | 0.01 | 0.00 | 7.0 |
433 | Level5 | GO:0042063 | gliogenesis | 9 | 1017 | 52 | 25202 | 5.69e-04 | 0.01 | 0.00 | 4.3 |
434 | Level5 | GO:0002764 | immune response\-regulating signal transduction | 8 | 1018 | 41 | 25213 | 5.71e-04 | 0.01 | 0.00 | 4.8 |
435 | Level4 | GO:0008343 | adult feeding behavior | 4 | 1022 | 7 | 25247 | 6.12e-04 | 0.00 | 0.00 | 14.1 |
436 | Level5 | GO:0051900 | regulation of mitochondrial depolarization | 4 | 1022 | 7 | 25247 | 6.12e-04 | 0.00 | 0.00 | 14.1 |
437 | Level5 | GO:0006643 | membrane lipid metabolic process | 23 | 1003 | 246 | 25008 | 6.46e-04 | 0.02 | 0.01 | 2.3 |
438 | Level4 | GO:0009410 | response to xenobiotic stimulus | 8 | 1018 | 42 | 25212 | 6.57e-04 | 0.01 | 0.00 | 4.7 |
439 | Level4 | GO:0042044 | fluid transport | 5 | 1021 | 14 | 25240 | 6.61e-04 | 0.00 | 0.00 | 8.8 |
440 | Level5 | GO:0031669 | cellular response to nutrient levels | 5 | 1021 | 14 | 25240 | 6.61e-04 | 0.00 | 0.00 | 8.8 |
441 | Level5 | GO:0001502 | cartilage condensation | 5 | 1021 | 14 | 25240 | 6.61e-04 | 0.00 | 0.00 | 8.8 |
442 | Level5 | GO:0006833 | water transport | 5 | 1021 | 14 | 25240 | 6.61e-04 | 0.00 | 0.00 | 8.8 |
443 | Level4 | GO:0007276 | gamete generation | 29 | 997 | 350 | 24904 | 6.71e-04 | 0.03 | 0.01 | 2.0 |
444 | Level5 | GO:0045216 | cell\-cell junction assembly and maintenance | 6 | 1020 | 23 | 25231 | 7.66e-04 | 0.01 | 0.00 | 6.4 |
445 | Level5 | GO:0001659 | temperature homeostasis | 20 | 1006 | 209 | 25045 | 8.06e-04 | 0.02 | 0.01 | 2.4 |
446 | Level5 | GO:0002697 | regulation of immune effector process | 7 | 1019 | 33 | 25221 | 8.17e-04 | 0.01 | 0.00 | 5.2 |
447 | Level5 | GO:0002367 | cytokine production during immune response | 5 | 1021 | 15 | 25239 | 8.53e-04 | 0.00 | 0.00 | 8.2 |
448 | Level5 | GO:0006997 | nuclear organization and biogenesis | 8 | 1018 | 44 | 25210 | 8.59e-04 | 0.01 | 0.00 | 4.5 |
449 | Level5 | GO:0046620 | regulation of organ growth | 4 | 1022 | 8 | 25246 | 8.89e-04 | 0.00 | 0.00 | 12.3 |
450 | Level5 | GO:0048634 | regulation of muscle development | 6 | 1020 | 24 | 25230 | 9.27e-04 | 0.01 | 0.00 | 6.2 |
451 | Level5 | GO:0003002 | regionalization | 16 | 1010 | 152 | 25102 | 9.32e-04 | 0.02 | 0.01 | 2.6 |
452 | Level4 | GO:0016192 | vesicle\-mediated transport | 45 | 981 | 654 | 24600 | 1.03e-03 | 0.04 | 0.03 | 1.7 |
453 | Level5 | GO:0001649 | osteoblast differentiation | 7 | 1019 | 35 | 25219 | 1.11e-03 | 0.01 | 0.00 | 4.9 |
454 | Level4 | GO:0022411 | cellular component disassembly | 6 | 1020 | 25 | 25229 | 1.11e-03 | 0.01 | 0.00 | 5.9 |
455 | Level4 | GO:0000051 | urea cycle intermediate metabolic process | 6 | 1020 | 25 | 25229 | 1.11e-03 | 0.01 | 0.00 | 5.9 |
456 | Level5 | GO:0042742 | defense response to bacterium | 13 | 1013 | 113 | 25141 | 1.32e-03 | 0.01 | 0.00 | 2.8 |
457 | Level5 | GO:0048628 | myoblast maturation | 6 | 1020 | 26 | 25228 | 1.32e-03 | 0.01 | 0.00 | 5.7 |
458 | Level5 | GO:0044264 | cellular polysaccharide metabolic process | 12 | 1014 | 100 | 25154 | 1.44e-03 | 0.01 | 0.00 | 3.0 |
459 | Level4 | GO:0001709 | cell fate determination | 7 | 1019 | 37 | 25217 | 1.47e-03 | 0.01 | 0.00 | 4.7 |
460 | Level4 | GO:0030900 | forebrain development | 11 | 1015 | 87 | 25167 | 1.54e-03 | 0.01 | 0.00 | 3.1 |
461 | Level4 | GO:0009880 | embryonic pattern specification | 8 | 1018 | 49 | 25205 | 1.59e-03 | 0.01 | 0.00 | 4.0 |
462 | Level4 | GO:0006869 | lipid transport | 13 | 1013 | 116 | 25138 | 1.64e-03 | 0.01 | 0.00 | 2.8 |
463 | Level3 | GO:0007611 | learning and/or memory | 11 | 1015 | 88 | 25166 | 1.67e-03 | 0.01 | 0.00 | 3.1 |
464 | Level5 | GO:0005976 | polysaccharide metabolic process | 12 | 1014 | 102 | 25152 | 1.68e-03 | 0.01 | 0.00 | 2.9 |
465 | Level4 | GO:0045776 | negative regulation of blood pressure | 5 | 1021 | 18 | 25236 | 1.68e-03 | 0.00 | 0.00 | 6.8 |
466 | Level5 | GO:0032845 | negative regulation of homeostatic process | 4 | 1022 | 10 | 25244 | 1.69e-03 | 0.00 | 0.00 | 9.8 |
467 | Level5 | GO:0048333 | mesodermal cell differentiation | 4 | 1022 | 10 | 25244 | 1.69e-03 | 0.00 | 0.00 | 9.8 |
468 | Level4 | GO:0031647 | regulation of protein stability | 6 | 1020 | 28 | 25226 | 1.84e-03 | 0.01 | 0.00 | 5.3 |
469 | Level5 | GO:0003073 | regulation of systemic arterial blood pressure | 6 | 1020 | 28 | 25226 | 1.84e-03 | 0.01 | 0.00 | 5.3 |
470 | Level5 | GO:0045444 | fat cell differentiation | 6 | 1020 | 28 | 25226 | 1.84e-03 | 0.01 | 0.00 | 5.3 |
471 | Level4 | GO:0032906 | transforming growth factor\-beta2 production | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
472 | Level4 | GO:0045136 | development of secondary sexual characteristics | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
473 | Level5 | GO:0046149 | pigment catabolic process | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
474 | Level5 | GO:0030258 | lipid modification | 7 | 1019 | 39 | 25215 | 1.92e-03 | 0.01 | 0.00 | 4.4 |
475 | Level5 | GO:0044272 | sulfur compound biosynthetic process | 8 | 1018 | 51 | 25203 | 1.99e-03 | 0.01 | 0.00 | 3.9 |
476 | Level5 | GO:0031279 | regulation of cyclase activity | 8 | 1018 | 52 | 25202 | 2.22e-03 | 0.01 | 0.00 | 3.8 |
477 | Level5 | GO:0051339 | regulation of lyase activity | 8 | 1018 | 52 | 25202 | 2.22e-03 | 0.01 | 0.00 | 3.8 |
478 | Level5 | GO:0030728 | ovulation | 4 | 1022 | 11 | 25243 | 2.23e-03 | 0.00 | 0.00 | 9.0 |
479 | Level4 | GO:0048736 | appendage development | 9 | 1017 | 65 | 25189 | 2.31e-03 | 0.01 | 0.00 | 3.4 |
480 | Level5 | GO:0035107 | appendage morphogenesis | 9 | 1017 | 65 | 25189 | 2.31e-03 | 0.01 | 0.00 | 3.4 |
481 | Level5 | GO:0060173 | limb development | 9 | 1017 | 65 | 25189 | 2.31e-03 | 0.01 | 0.00 | 3.4 |
482 | Level5 | GO:0006119 | oxidative phosphorylation | 12 | 1014 | 107 | 25147 | 2.42e-03 | 0.01 | 0.00 | 2.8 |
483 | Level4 | GO:0006730 | one\-carbon compound metabolic process | 13 | 1013 | 122 | 25132 | 2.46e-03 | 0.01 | 0.00 | 2.6 |
484 | Level4 | GO:0006081 | aldehyde metabolic process | 5 | 1021 | 20 | 25234 | 2.49e-03 | 0.00 | 0.00 | 6.2 |
485 | Level3 | GO:0035265 | organ growth | 4 | 1022 | 12 | 25242 | 2.88e-03 | 0.00 | 0.00 | 8.2 |
486 | Level4 | GO:0043331 | response to dsRNA | 4 | 1022 | 12 | 25242 | 2.88e-03 | 0.00 | 0.00 | 8.2 |
487 | Level5 | GO:0045124 | regulation of bone resorption | 4 | 1022 | 12 | 25242 | 2.88e-03 | 0.00 | 0.00 | 8.2 |
488 | Level5 | GO:0001504 | neurotransmitter uptake | 4 | 1022 | 12 | 25242 | 2.88e-03 | 0.00 | 0.00 | 8.2 |
489 | Level4 | GO:0045785 | positive regulation of cell adhesion | 5 | 1021 | 21 | 25233 | 2.98e-03 | 0.00 | 0.00 | 5.9 |
490 | Level4 | GO:0032640 | tumor necrosis factor production | 5 | 1021 | 21 | 25233 | 2.98e-03 | 0.00 | 0.00 | 5.9 |
491 | Level5 | GO:0006944 | membrane fusion | 8 | 1018 | 55 | 25199 | 3.03e-03 | 0.01 | 0.00 | 3.6 |
492 | Level5 | GO:0006022 | aminoglycan metabolic process | 8 | 1018 | 55 | 25199 | 3.03e-03 | 0.01 | 0.00 | 3.6 |
493 | Level5 | GO:0050905 | neuromuscular process | 7 | 1019 | 43 | 25211 | 3.12e-03 | 0.01 | 0.00 | 4.0 |
494 | Level4 | GO:0030238 | male sex determination | 4 | 1022 | 13 | 25241 | 3.66e-03 | 0.00 | 0.00 | 7.6 |
495 | Level4 | GO:0006970 | response to osmotic stress | 4 | 1022 | 13 | 25241 | 3.66e-03 | 0.00 | 0.00 | 7.6 |
496 | Level5 | GO:0002062 | chondrocyte differentiation | 4 | 1022 | 13 | 25241 | 3.66e-03 | 0.00 | 0.00 | 7.6 |
497 | Level5 | GO:0006778 | porphyrin metabolic process | 6 | 1020 | 33 | 25221 | 3.78e-03 | 0.01 | 0.00 | 4.5 |
498 | Level5 | GO:0033013 | tetrapyrrole metabolic process | 6 | 1020 | 33 | 25221 | 3.78e-03 | 0.01 | 0.00 | 4.5 |
499 | Level4 | GO:0046660 | female sex differentiation | 7 | 1019 | 45 | 25209 | 3.91e-03 | 0.01 | 0.00 | 3.8 |
500 | Level5 | GO:0046545 | development of primary female sexual characteristics | 7 | 1019 | 45 | 25209 | 3.91e-03 | 0.01 | 0.00 | 3.8 |
501 | Level5 | GO:0043450 | alkene biosynthetic process | 5 | 1021 | 23 | 25231 | 4.18e-03 | 0.00 | 0.00 | 5.4 |
502 | Level5 | GO:0007500 | mesodermal cell fate determination | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
503 | Level5 | GO:0048284 | organelle fusion | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
504 | Level5 | GO:0048732 | gland development | 9 | 1017 | 72 | 25182 | 4.28e-03 | 0.01 | 0.00 | 3.1 |
505 | Level4 | GO:0007569 | cell aging | 4 | 1022 | 14 | 25240 | 4.56e-03 | 0.00 | 0.00 | 7.0 |
506 | Level4 | GO:0032637 | interleukin\-8 production | 4 | 1022 | 14 | 25240 | 4.56e-03 | 0.00 | 0.00 | 7.0 |
507 | Level4 | GO:0022607 | cellular component assembly | 21 | 1005 | 261 | 24993 | 4.73e-03 | 0.02 | 0.01 | 2.0 |
508 | Level5 | GO:0042698 | ovulation cycle | 7 | 1019 | 47 | 25207 | 4.84e-03 | 0.01 | 0.00 | 3.7 |
509 | Level5 | GO:0001570 | vasculogenesis | 6 | 1020 | 35 | 25219 | 4.88e-03 | 0.01 | 0.00 | 4.2 |
510 | Level5 | GO:0007269 | neurotransmitter secretion | 8 | 1018 | 60 | 25194 | 4.89e-03 | 0.01 | 0.00 | 3.3 |
511 | Level5 | GO:0007589 | body fluid secretion | 5 | 1021 | 24 | 25230 | 4.89e-03 | 0.00 | 0.00 | 5.1 |
512 | Level4 | GO:0006959 | humoral immune response | 10 | 1016 | 88 | 25166 | 4.95e-03 | 0.01 | 0.00 | 2.8 |
513 | Level4 | GO:0007162 | negative regulation of cell adhesion | 7 | 1019 | 48 | 25206 | 5.37e-03 | 0.01 | 0.00 | 3.6 |
514 | Level5 | GO:0007009 | plasma membrane organization and biogenesis | 4 | 1022 | 15 | 25239 | 5.60e-03 | 0.00 | 0.00 | 6.6 |
515 | Level4 | GO:0032623 | interleukin\-2 production | 5 | 1021 | 25 | 25229 | 5.68e-03 | 0.00 | 0.00 | 4.9 |
516 | Level5 | GO:0009309 | amine biosynthetic process | 10 | 1016 | 90 | 25164 | 5.71e-03 | 0.01 | 0.00 | 2.7 |
517 | Level5 | GO:0043330 | response to exogenous dsRNA | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
518 | Level5 | GO:0045342 | MHC class II biosynthetic process | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
519 | Level4 | GO:0022415 | viral reproductive process | 8 | 1018 | 63 | 25191 | 6.35e-03 | 0.01 | 0.00 | 3.1 |
520 | Level5 | GO:0007292 | female gamete generation | 7 | 1019 | 50 | 25204 | 6.54e-03 | 0.01 | 0.00 | 3.4 |
521 | Level5 | GO:0009408 | response to heat | 4 | 1022 | 16 | 25238 | 6.79e-03 | 0.00 | 0.00 | 6.2 |
522 | Level5 | GO:0045069 | regulation of viral genome replication | 4 | 1022 | 16 | 25238 | 6.79e-03 | 0.00 | 0.00 | 6.2 |
523 | Level4 | GO:0006805 | xenobiotic metabolic process | 6 | 1020 | 38 | 25216 | 6.94e-03 | 0.01 | 0.00 | 3.9 |
524 | Level5 | GO:0019079 | viral genome replication | 6 | 1020 | 38 | 25216 | 6.94e-03 | 0.01 | 0.00 | 3.9 |
525 | Level5 | GO:0006576 | biogenic amine metabolic process | 9 | 1017 | 79 | 25175 | 7.38e-03 | 0.01 | 0.00 | 2.8 |
526 | Level3 | GO:0022406 | membrane docking | 5 | 1021 | 27 | 25227 | 7.53e-03 | 0.00 | 0.00 | 4.6 |
527 | Level4 | GO:0043449 | alkene metabolic process | 5 | 1021 | 27 | 25227 | 7.53e-03 | 0.00 | 0.00 | 4.6 |
528 | Level4 | GO:0048278 | vesicle docking | 5 | 1021 | 27 | 25227 | 7.53e-03 | 0.00 | 0.00 | 4.6 |
529 | Level5 | GO:0006691 | leukotriene metabolic process | 5 | 1021 | 27 | 25227 | 7.53e-03 | 0.00 | 0.00 | 4.6 |
530 | Level4 | GO:0021534 | cell proliferation in hindbrain | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
531 | Level4 | GO:0031341 | regulation of cell killing | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
532 | Level5 | GO:0021924 | cell proliferation in the external granule layer | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
533 | Level5 | GO:0001910 | regulation of leukocyte mediated cytotoxicity | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
534 | Level4 | GO:0030902 | hindbrain development | 6 | 1020 | 39 | 25215 | 7.74e-03 | 0.01 | 0.00 | 3.8 |
535 | Level2 | GO:0001906 | cell killing | 4 | 1022 | 17 | 25237 | 8.13e-03 | 0.00 | 0.00 | 5.8 |
536 | Level5 | GO:0015671 | oxygen transport | 4 | 1022 | 17 | 25237 | 8.13e-03 | 0.00 | 0.00 | 5.8 |
537 | Level5 | GO:0045168 | cell\-cell signaling during cell fate commitment | 4 | 1022 | 17 | 25237 | 8.13e-03 | 0.00 | 0.00 | 5.8 |
538 | Level5 | GO:0009409 | response to cold | 17 | 1009 | 207 | 25047 | 8.42e-03 | 0.02 | 0.01 | 2.0 |
539 | Level4 | GO:0010248 | establishment and/or maintenance of transmembrane electrochemical gradient | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
540 | Level4 | GO:0046950 | ketone body metabolic process | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
541 | Level4 | GO:0051409 | response to nitrosative stress | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
542 | Level5 | GO:0046543 | development of secondary female sexual characteristics | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
543 | Level5 | GO:0046544 | development of secondary male sexual characteristics | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
544 | Level5 | GO:0033194 | response to hydroperoxide | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
545 | Level5 | GO:0050931 | pigment cell differentiation | 4 | 1022 | 18 | 25236 | 9.63e-03 | 0.00 | 0.00 | 5.5 |
546 | Level4 | GO:0001935 | endothelial cell proliferation | 5 | 1021 | 29 | 25225 | 9.75e-03 | 0.00 | 0.00 | 4.2 |
547 | Level4 | GO:0048002 | antigen processing and presentation of peptide antigen | 5 | 1021 | 29 | 25225 | 9.75e-03 | 0.00 | 0.00 | 4.2 |
548 | Level4 | GO:0006986 | response to unfolded protein | 9 | 1017 | 83 | 25171 | 9.78e-03 | 0.01 | 0.00 | 2.7 |
549 | Level4 | GO:0051789 | response to protein stimulus | 9 | 1017 | 83 | 25171 | 9.78e-03 | 0.01 | 0.00 | 2.7 |
550 | Level4 | GO:0001710 | mesodermal cell fate commitment | 3 | 1023 | 9 | 25245 | 1.00e-02 | 0.00 | 0.00 | 8.2 |
551 | Level5 | GO:0050808 | synapse organization and biogenesis | 8 | 1018 | 69 | 25185 | 1.03e-02 | 0.01 | 0.00 | 2.9 |
552 | Level5 | GO:0018958 | phenol metabolic process | 8 | 1018 | 70 | 25184 | 1.10e-02 | 0.01 | 0.00 | 2.8 |
553 | Level5 | GO:0045471 | response to ethanol | 4 | 1022 | 19 | 25235 | 1.13e-02 | 0.00 | 0.00 | 5.2 |
554 | Level5 | GO:0046546 | development of primary male sexual characteristics | 6 | 1020 | 43 | 25211 | 1.17e-02 | 0.01 | 0.00 | 3.4 |
555 | Level3 | GO:0042303 | molting cycle | 5 | 1021 | 31 | 25223 | 1.24e-02 | 0.00 | 0.00 | 4.0 |
556 | Level4 | GO:0042633 | hair cycle | 5 | 1021 | 31 | 25223 | 1.24e-02 | 0.00 | 0.00 | 4.0 |
557 | Level4 | GO:0022404 | molting cycle process | 5 | 1021 | 31 | 25223 | 1.24e-02 | 0.00 | 0.00 | 4.0 |
558 | Level5 | GO:0022405 | hair cycle process | 5 | 1021 | 31 | 25223 | 1.24e-02 | 0.00 | 0.00 | 4.0 |
559 | Level4 | GO:0015031 | protein transport | 52 | 974 | 887 | 24367 | 1.25e-02 | 0.05 | 0.04 | 1.4 |
560 | Level4 | GO:0010469 | regulation of receptor activity | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
561 | Level5 | GO:0042312 | regulation of vasodilation | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
562 | Level5 | GO:0042755 | eating behavior | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
563 | Level5 | GO:0048547 | gut morphogenesis | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
564 | Level2 | GO:0016032 | viral reproduction | 8 | 1018 | 72 | 25182 | 1.28e-02 | 0.01 | 0.00 | 2.7 |
565 | Level5 | GO:0043393 | regulation of protein binding | 4 | 1022 | 20 | 25234 | 1.32e-02 | 0.00 | 0.00 | 4.9 |
566 | Level5 | GO:0050821 | protein stabilization | 4 | 1022 | 20 | 25234 | 1.32e-02 | 0.00 | 0.00 | 4.9 |
567 | Level4 | GO:0007530 | sex determination | 5 | 1021 | 32 | 25222 | 1.39e-02 | 0.00 | 0.00 | 3.8 |
568 | Level4 | GO:0030185 | nitric oxide transport | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
569 | Level4 | GO:0042335 | cuticle development | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
570 | Level4 | GO:0002266 | follicular dendritic cell activation | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
571 | Level5 | GO:0050665 | hydrogen peroxide biosynthetic process | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
572 | Level5 | GO:0060037 | pharyngeal system development | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
573 | Level5 | GO:0032846 | positive regulation of homeostatic process | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
574 | Level5 | GO:0044273 | sulfur compound catabolic process | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
575 | Level5 | GO:0022612 | gland morphogenesis | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
576 | Level5 | GO:0002268 | follicular dendritic cell differentiation | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
577 | Level4 | GO:0015669 | gas transport | 4 | 1022 | 21 | 25233 | 1.52e-02 | 0.00 | 0.00 | 4.7 |
578 | Level5 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 4 | 1022 | 21 | 25233 | 1.52e-02 | 0.00 | 0.00 | 4.7 |
579 | Level4 | GO:0030901 | midbrain development | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
580 | Level5 | GO:0015908 | fatty acid transport | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
581 | Level5 | GO:0002444 | myeloid leukocyte mediated immunity | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
582 | Level5 | GO:0006582 | melanin metabolic process | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
583 | Level4 | GO:0009612 | response to mechanical stimulus | 5 | 1021 | 34 | 25220 | 1.72e-02 | 0.00 | 0.00 | 3.6 |
584 | Level4 | GO:0050792 | regulation of viral reproduction | 4 | 1022 | 22 | 25232 | 1.74e-02 | 0.00 | 0.00 | 4.5 |
585 | Level5 | GO:0046148 | pigment biosynthetic process | 6 | 1020 | 48 | 25206 | 1.83e-02 | 0.01 | 0.00 | 3.1 |
586 | Level4 | GO:0044241 | lipid digestion | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
587 | Level5 | GO:0048599 | oocyte development | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
588 | Level5 | GO:0014855 | striated muscle cell proliferation | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
589 | Level4 | GO:0008344 | adult locomotory behavior | 5 | 1021 | 35 | 25219 | 1.91e-02 | 0.00 | 0.00 | 3.5 |
590 | Level4 | GO:0045087 | innate immune response | 11 | 1015 | 121 | 25133 | 1.96e-02 | 0.01 | 0.00 | 2.2 |
591 | Level4 | GO:0007613 | memory | 4 | 1022 | 23 | 25231 | 1.98e-02 | 0.00 | 0.00 | 4.3 |
592 | Level5 | GO:0015914 | phospholipid transport | 4 | 1022 | 23 | 25231 | 1.98e-02 | 0.00 | 0.00 | 4.3 |
593 | Level5 | GO:0048667 | neuron morphogenesis during differentiation | 16 | 1010 | 204 | 25050 | 2.05e-02 | 0.02 | 0.01 | 1.9 |
594 | Level4 | GO:0051775 | response to redox state | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
595 | Level5 | GO:0052173 | response to defenses of other organism during symbiotic interaction | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
596 | Level5 | GO:0006980 | redox signal response | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
597 | Level5 | GO:0021871 | forebrain regionalization | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
598 | Level5 | GO:0001667 | ameboidal cell migration | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
599 | Level5 | GO:0009238 | enterobactin metabolic process | 5 | 1021 | 36 | 25218 | 2.10e-02 | 0.00 | 0.00 | 3.4 |
600 | Level5 | GO:0009237 | siderophore metabolic process | 5 | 1021 | 36 | 25218 | 2.10e-02 | 0.00 | 0.00 | 3.4 |
601 | Level5 | GO:0051640 | organelle localization | 6 | 1020 | 50 | 25204 | 2.16e-02 | 0.01 | 0.00 | 3.0 |
602 | Level4 | GO:0001708 | cell fate specification | 4 | 1022 | 24 | 25230 | 2.24e-02 | 0.00 | 0.00 | 4.1 |
603 | Level3 | GO:0007567 | parturition | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
604 | Level3 | GO:0001909 | leukocyte mediated cytotoxicity | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
605 | Level4 | GO:0043603 | amide metabolic process | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
606 | Level5 | GO:0048638 | regulation of developmental growth | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
607 | Level5 | GO:0009994 | oocyte differentiation | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
608 | Level5 | GO:0019627 | urea metabolic process | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
609 | Level5 | GO:0035272 | exocrine system development | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
610 | Level2 | GO:0048511 | rhythmic process | 9 | 1017 | 97 | 25157 | 2.30e-02 | 0.01 | 0.00 | 2.3 |
611 | Level5 | GO:0006029 | proteoglycan metabolic process | 5 | 1021 | 37 | 25217 | 2.31e-02 | 0.00 | 0.00 | 3.3 |
612 | Level4 | GO:0022600 | digestive system process | 4 | 1022 | 25 | 25229 | 2.52e-02 | 0.00 | 0.00 | 3.9 |
613 | Level4 | GO:0000904 | cellular morphogenesis during differentiation | 16 | 1010 | 216 | 25038 | 2.55e-02 | 0.02 | 0.01 | 1.8 |
614 | Level5 | GO:0050832 | defense response to fungus | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
615 | Level5 | GO:0035051 | cardiac cell differentiation | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
616 | Level3 | GO:0008037 | cell recognition | 6 | 1020 | 53 | 25201 | 2.71e-02 | 0.01 | 0.00 | 2.8 |
617 | Level4 | GO:0010463 | mesenchymal cell proliferation | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
618 | Level5 | GO:0042832 | defense response to protozoan | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
619 | Level5 | GO:0031641 | regulation of myelination | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
620 | Level5 | GO:0009110 | vitamin biosynthetic process | 4 | 1022 | 26 | 25228 | 2.82e-02 | 0.00 | 0.00 | 3.8 |
621 | Level5 | GO:0032259 | methylation | 7 | 1019 | 69 | 25185 | 2.88e-02 | 0.01 | 0.00 | 2.5 |
622 | Level4 | GO:0000910 | cytokinesis | 5 | 1021 | 40 | 25214 | 3.02e-02 | 0.00 | 0.00 | 3.1 |
623 | Level5 | GO:0050892 | intestinal absorption | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
624 | Level5 | GO:0010212 | response to ionizing radiation | 4 | 1022 | 27 | 25227 | 3.14e-02 | 0.00 | 0.00 | 3.6 |
625 | Level4 | GO:0002437 | inflammatory response to antigenic stimulus | 6 | 1020 | 57 | 25197 | 3.60e-02 | 0.01 | 0.00 | 2.6 |
626 | Level5 | GO:0019058 | viral infectious cycle | 6 | 1020 | 57 | 25197 | 3.60e-02 | 0.01 | 0.00 | 2.6 |
627 | Level5 | GO:0048806 | genitalia development | 3 | 1023 | 16 | 25238 | 3.60e-02 | 0.00 | 0.00 | 4.6 |
628 | Level4 | GO:0002347 | response to tumor cell | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
629 | Level4 | GO:0040012 | regulation of locomotion | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
630 | Level4 | GO:0032604 | granulocyte macrophage colony\-stimulating factor production | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
631 | Level4 | GO:0002076 | osteoblast development | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
632 | Level4 | GO:0032870 | cellular response to hormone stimulus | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
633 | Level5 | GO:0031343 | positive regulation of cell killing | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
634 | Level5 | GO:0032869 | cellular response to insulin stimulus | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
635 | Level5 | GO:0032611 | interleukin\-1 beta production | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
636 | Level4 | GO:0032535 | regulation of cellular component size | 6 | 1020 | 58 | 25196 | 3.84e-02 | 0.01 | 0.00 | 2.5 |
637 | Level5 | GO:0014070 | response to organic cyclic substance | 4 | 1022 | 29 | 25225 | 3.85e-02 | 0.00 | 0.00 | 3.4 |
638 | Level5 | GO:0006820 | anion transport | 18 | 1008 | 261 | 24993 | 4.08e-02 | 0.02 | 0.01 | 1.7 |
639 | Level4 | GO:0021782 | glial cell development | 3 | 1023 | 17 | 25237 | 4.12e-02 | 0.00 | 0.00 | 4.3 |
640 | Level4 | GO:0002263 | cell activation during immune response | 3 | 1023 | 17 | 25237 | 4.12e-02 | 0.00 | 0.00 | 4.3 |
641 | Level5 | GO:0002366 | leukocyte activation during immune response | 3 | 1023 | 17 | 25237 | 4.12e-02 | 0.00 | 0.00 | 4.3 |
642 | Level5 | GO:0045814 | negative regulation of gene expression\, epigenetic | 3 | 1023 | 17 | 25237 | 4.12e-02 | 0.00 | 0.00 | 4.3 |
643 | Level4 | GO:0015837 | amine transport | 9 | 1017 | 102 | 25152 | 4.18e-02 | 0.01 | 0.00 | 2.2 |
644 | Level4 | GO:0007612 | learning | 5 | 1021 | 45 | 25209 | 4.48e-02 | 0.00 | 0.00 | 2.7 |
645 | Level3 | GO:0030431 | sleep | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
646 | Level4 | GO:0001562 | response to protozoan | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
647 | Level4 | GO:0032613 | interleukin\-10 production | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
648 | Level4 | GO:0032612 | interleukin\-1 production | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
649 | Level5 | GO:0048678 | response to axon injury | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
650 | Level5 | GO:0006972 | hyperosmotic response | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
651 | Level5 | GO:0048558 | embryonic gut morphogenesis | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
652 | Level5 | GO:0021511 | spinal cord patterning | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
653 | Level4 | GO:0051180 | vitamin transport | 3 | 1023 | 18 | 25236 | 4.67e-02 | 0.00 | 0.00 | 4.1 |
654 | Level5 | GO:0022408 | negative regulation of cell\-cell adhesion | 3 | 1023 | 18 | 25236 | 4.67e-02 | 0.00 | 0.00 | 4.1 |
655 | Level5 | GO:0048729 | tissue morphogenesis | 9 | 1017 | 107 | 25147 | 4.78e-02 | 0.01 | 0.00 | 2.1 |
656 | Level4 | GO:0007618 | mating | 3 | 1023 | 19 | 25235 | 5.26e-02 | 0.00 | 0.00 | 3.9 |
657 | Level5 | GO:0022603 | regulation of anatomical structure morphogenesis | 9 | 1017 | 112 | 25142 | 5.56e-02 | 0.01 | 0.00 | 2.0 |
658 | Level4 | GO:0043094 | metabolic compound salvage | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
659 | Level5 | GO:0048525 | negative regulation of viral reproduction | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
660 | Level5 | GO:0001556 | oocyte maturation | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
661 | Level5 | GO:0001881 | receptor recycling | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
662 | Level5 | GO:0033205 | cytokinesis during cell cycle | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
663 | Level5 | GO:0015884 | folic acid transport | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
664 | Level5 | GO:0005984 | disaccharide metabolic process | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
665 | Level5 | GO:0051276 | chromosome organization and biogenesis | 31 | 995 | 529 | 24725 | 5.94e-02 | 0.03 | 0.02 | 1.4 |
666 | Level3 | GO:0055114 | oxidation reduction | 5 | 1021 | 50 | 25204 | 6.29e-02 | 0.00 | 0.00 | 2.5 |
667 | Level5 | GO:0022900 | electron transport chain | 5 | 1021 | 50 | 25204 | 6.29e-02 | 0.00 | 0.00 | 2.5 |
668 | Level5 | GO:0043279 | response to alkaloid | 3 | 1023 | 21 | 25233 | 6.53e-02 | 0.00 | 0.00 | 3.5 |
669 | Level3 | GO:0044419 | interspecies interaction between organisms | 6 | 1020 | 67 | 25187 | 6.54e-02 | 0.01 | 0.00 | 2.2 |
670 | Level4 | GO:0044403 | symbiosis\, encompassing mutualism through parasitism | 6 | 1020 | 67 | 25187 | 6.54e-02 | 0.01 | 0.00 | 2.2 |
671 | Level4 | GO:0021675 | nerve development | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
672 | Level5 | GO:0045793 | positive regulation of cell size | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
673 | Level5 | GO:0014075 | response to amine stimulus | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
674 | Level5 | GO:0051340 | regulation of ligase activity | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
675 | Level4 | GO:0048839 | inner ear development | 6 | 1020 | 68 | 25186 | 6.89e-02 | 0.01 | 0.00 | 2.2 |
676 | Level4 | GO:0006836 | neurotransmitter transport | 6 | 1020 | 68 | 25186 | 6.89e-02 | 0.01 | 0.00 | 2.2 |
677 | Level3 | GO:0007566 | embryo implantation | 3 | 1023 | 22 | 25232 | 7.21e-02 | 0.00 | 0.00 | 3.4 |
678 | Level4 | GO:0051607 | defense response to virus | 3 | 1023 | 22 | 25232 | 7.21e-02 | 0.00 | 0.00 | 3.4 |
679 | Level4 | GO:0032609 | interferon\-gamma production | 3 | 1023 | 22 | 25232 | 7.21e-02 | 0.00 | 0.00 | 3.4 |
680 | Level5 | GO:0022407 | regulation of cell\-cell adhesion | 3 | 1023 | 22 | 25232 | 7.21e-02 | 0.00 | 0.00 | 3.4 |
681 | Level5 | GO:0007628 | adult walking behavior | 3 | 1023 | 22 | 25232 | 7.21e-02 | 0.00 | 0.00 | 3.4 |
682 | Level3 | GO:0000746 | conjugation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
683 | Level3 | GO:0006894 | Golgi to secretory vesicle transport | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
684 | Level3 | GO:0043696 | dedifferentiation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
685 | Level4 | GO:0048143 | astrocyte activation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
686 | Level4 | GO:0000747 | conjugation with cellular fusion | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
687 | Level4 | GO:0010149 | senescence | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
688 | Level4 | GO:0032601 | connective tissue growth factor production | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
689 | Level4 | GO:0043697 | cell dedifferentiation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
690 | Level4 | GO:0002251 | organ or tissue specific immune response | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
691 | Level4 | GO:0042684 | cardioblast cell fate commitment | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
692 | Level5 | GO:0002439 | chronic inflammatory response to antigenic stimulus | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
693 | Level5 | GO:0043117 | positive regulation of vascular permeability | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
694 | Level5 | GO:0009814 | defense response\, incompatible interaction | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
695 | Level5 | GO:0051767 | nitric\-oxide synthase biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
696 | Level5 | GO:0051095 | regulation of helicase activity | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
697 | Level5 | GO:0018904 | organic ether metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
698 | Level5 | GO:0009730 | detection of carbohydrate stimulus | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
699 | Level5 | GO:0045056 | transcytosis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
700 | Level5 | GO:0001941 | postsynaptic membrane organization | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
701 | Level5 | GO:0046185 | aldehyde catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
702 | Level5 | GO:0031342 | negative regulation of cell killing | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
703 | Level5 | GO:0010046 | response to mycotoxin | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
704 | Level5 | GO:0002227 | innate immune response in mucosa | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
705 | Level5 | GO:0002385 | mucosal immune response | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
706 | Level5 | GO:0065005 | protein\-lipid complex assembly | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
707 | Level5 | GO:0009854 | oxidative photosynthetic carbon pathway | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
708 | Level5 | GO:0009853 | photorespiration | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
709 | Level5 | GO:0060082 | eye blink reflex | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
710 | Level5 | GO:0060019 | radial glial cell differentiation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
711 | Level5 | GO:0019682 | glyceraldehyde\-3\-phosphate metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
712 | Level5 | GO:0042262 | DNA protection | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
713 | Level5 | GO:0042685 | cardioblast cell fate specification | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
714 | Level2 | GO:0040011 | locomotion | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
715 | Level4 | GO:0007028 | cytoplasm organization and biogenesis | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
716 | Level4 | GO:0009268 | response to pH | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
717 | Level5 | GO:0042375 | quinone cofactor metabolic process | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
718 | Level5 | GO:0016050 | vesicle organization and biogenesis | 3 | 1023 | 23 | 25231 | 7.93e-02 | 0.00 | 0.00 | 3.2 |
719 | Level5 | GO:0009112 | nucleobase metabolic process | 3 | 1023 | 24 | 25230 | 8.67e-02 | 0.00 | 0.00 | 3.1 |
720 | Level5 | GO:0002438 | acute inflammatory response to antigenic stimulus | 5 | 1021 | 56 | 25198 | 8.93e-02 | 0.00 | 0.00 | 2.2 |
721 | Level5 | GO:0031069 | hair follicle morphogenesis | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
722 | Level5 | GO:0003085 | negative regulation of systemic arterial blood pressure | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
723 | Level5 | GO:0032594 | protein transport within lipid bilayer | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
724 | Level5 | GO:0006857 | oligopeptide transport | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
725 | Level5 | GO:0042430 | indole and derivative metabolic process | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
726 | Level5 | GO:0006865 | amino acid transport | 7 | 1019 | 83 | 25171 | 8.98e-02 | 0.01 | 0.00 | 2.1 |
727 | Level5 | GO:0051701 | interaction with host | 3 | 1023 | 25 | 25229 | 9.44e-02 | 0.00 | 0.00 | 3.0 |
728 | Level4 | GO:0007617 | mating behavior | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
729 | Level3 | GO:0045192 | low\-density lipoprotein catabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
730 | Level4 | GO:0009726 | detection of endogenous stimulus | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
731 | Level4 | GO:0034097 | response to cytokine stimulus | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
732 | Level4 | GO:0032835 | glomerulus development | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
733 | Level4 | GO:0032905 | transforming growth factor\-beta1 production | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
734 | Level5 | GO:0042756 | drinking behavior | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
735 | Level5 | GO:0002544 | chronic inflammatory response | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
736 | Level5 | GO:0032847 | regulation of cellular pH reduction | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
737 | Level5 | GO:0033598 | mammary gland epithelial cell proliferation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
738 | Level5 | GO:0046415 | urate metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
739 | Level5 | GO:0051937 | catecholamine transport | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
740 | Level5 | GO:0016046 | detection of fungus | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
741 | Level5 | GO:0000053 | argininosuccinate metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
742 | Level5 | GO:0007616 | long\-term memory | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
743 | Level5 | GO:0040013 | negative regulation of locomotion | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
744 | Level5 | GO:0051960 | regulation of nervous system development | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
745 | Level5 | GO:0019102 | male somatic sex determination | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
746 | Level5 | GO:0006931 | substrate\-bound cell migration\, cell attachment to substrate | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
747 | Level5 | GO:0021602 | cranial nerve morphogenesis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
748 | Level5 | GO:0001878 | response to yeast | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
749 | Level5 | GO:0009448 | gamma\-aminobutyric acid metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
750 | Level5 | GO:0050757 | thymidylate synthase biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
751 | Level5 | GO:0015888 | thiamin transport | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
752 | Level4 | GO:0032606 | type I interferon production | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
753 | Level5 | GO:0006929 | substrate\-bound cell migration | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
754 | Level5 | GO:0007052 | mitotic spindle organization and biogenesis | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
755 | Level4 | GO:0021510 | spinal cord development | 2 | 1024 | 14 | 25240 | 1.27e-01 | 0.00 | 0.00 | 3.5 |
756 | Level5 | GO:0042490 | mechanoreceptor differentiation | 3 | 1023 | 29 | 25225 | 1.28e-01 | 0.00 | 0.00 | 2.5 |
757 | Level5 | GO:0048489 | synaptic vesicle transport | 3 | 1023 | 29 | 25225 | 1.28e-01 | 0.00 | 0.00 | 2.5 |
758 | Level3 | GO:0051606 | detection of stimulus | 7 | 1019 | 98 | 25156 | 1.32e-01 | 0.01 | 0.00 | 1.8 |
759 | Level5 | GO:0006720 | isoprenoid metabolic process | 3 | 1023 | 30 | 25224 | 1.37e-01 | 0.00 | 0.00 | 2.5 |
760 | Level5 | GO:0031016 | pancreas development | 2 | 1024 | 15 | 25239 | 1.41e-01 | 0.00 | 0.00 | 3.3 |
761 | Level5 | GO:0051668 | localization within membrane | 2 | 1024 | 15 | 25239 | 1.41e-01 | 0.00 | 0.00 | 3.3 |
762 | Level3 | GO:0002507 | tolerance induction | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
763 | Level4 | GO:0009629 | response to gravity | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
764 | Level4 | GO:0001101 | response to acid | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
765 | Level4 | GO:0002418 | immune response to tumor cell | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
766 | Level4 | GO:0032616 | interleukin\-13 production | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
767 | Level4 | GO:0007412 | axon target recognition | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
768 | Level4 | GO:0032632 | interleukin\-3 production | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
769 | Level4 | GO:0018993 | somatic sex determination | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
770 | Level4 | GO:0040016 | embryonic cleavage | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
771 | Level5 | GO:0008065 | establishment of blood\-nerve barrier | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
772 | Level5 | GO:0030300 | regulation of cholesterol absorption | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
773 | Level5 | GO:0006862 | nucleotide transport | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
774 | Level5 | GO:0009651 | response to salt stress | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
775 | Level5 | GO:0033365 | protein localization in organelle | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
776 | Level5 | GO:0051231 | spindle elongation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
777 | Level5 | GO:0044240 | multicellular organismal lipid catabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
778 | Level5 | GO:0045475 | locomotor rhythm | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
779 | Level5 | GO:0002238 | response to molecule of fungal origin | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
780 | Level5 | GO:0006600 | creatine metabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
781 | Level4 | GO:0019098 | reproductive behavior | 2 | 1024 | 16 | 25238 | 1.55e-01 | 0.00 | 0.00 | 3.1 |
782 | Level5 | GO:0016339 | calcium\-dependent cell\-cell adhesion | 3 | 1023 | 32 | 25222 | 1.55e-01 | 0.00 | 0.00 | 2.3 |
783 | Level5 | GO:0045446 | endothelial cell differentiation | 2 | 1024 | 17 | 25237 | 1.69e-01 | 0.00 | 0.00 | 2.9 |
784 | Level5 | GO:0046942 | carboxylic acid transport | 11 | 1015 | 173 | 25081 | 1.75e-01 | 0.01 | 0.01 | 1.6 |
785 | Level4 | GO:0015849 | organic acid transport | 11 | 1015 | 174 | 25080 | 1.76e-01 | 0.01 | 0.01 | 1.6 |
786 | Level3 | GO:0031640 | killing of cells of another organism | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
787 | Level3 | GO:0035188 | hatching | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
788 | Level4 | GO:0051715 | cytolysis of cells of another organism | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
789 | Level4 | GO:0051883 | killing of cells in other organism during symbiotic interaction | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
790 | Level4 | GO:0043114 | regulation of vascular permeability | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
791 | Level4 | GO:0055013 | cardiac muscle cell development | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
792 | Level4 | GO:0002088 | lens development in camera\-type eye | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
793 | Level4 | GO:0008218 | bioluminescence | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
794 | Level4 | GO:0048148 | behavioral response to cocaine | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
795 | Level4 | GO:0060011 | Sertoli cell proliferation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
796 | Level4 | GO:0002063 | chondrocyte development | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
797 | Level4 | GO:0003016 | respiratory system process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
798 | Level4 | GO:0006991 | response to sterol depletion | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
799 | Level5 | GO:0014044 | Schwann cell development | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
800 | Level5 | GO:0051801 | cytolysis of cells in other organism during symbiotic interaction | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
801 | Level5 | GO:0001907 | killing by symbiont of host cells | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
802 | Level5 | GO:0051817 | modification of morphology or physiology of other organism during symbiotic interaction | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
803 | Level5 | GO:0040009 | regulation of growth rate | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
804 | Level5 | GO:0032801 | receptor catabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
805 | Level5 | GO:0042537 | benzene and derivative metabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
806 | Level5 | GO:0055003 | cardiac myofibril assembly | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
807 | Level5 | GO:0015872 | dopamine transport | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
808 | Level5 | GO:0021532 | neural tube patterning | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
809 | Level5 | GO:0048103 | somatic stem cell division | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
810 | Level5 | GO:0000320 | re\-entry into mitotic cell cycle | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
811 | Level5 | GO:0043174 | nucleoside salvage | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
812 | Level5 | GO:0043101 | purine salvage | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
813 | Level5 | GO:0042441 | eye pigment metabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
814 | Level5 | GO:0046487 | glyoxylate metabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
815 | Level5 | GO:0019471 | 4\-hydroxyproline metabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
816 | Level5 | GO:0048611 | embryonic ectodermal gut development | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
817 | Level5 | GO:0048070 | regulation of pigmentation during development | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
818 | Level5 | GO:0021545 | cranial nerve development | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
819 | Level5 | GO:0019730 | antimicrobial humoral response | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
820 | Level5 | GO:0044269 | glycerol ether catabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
821 | Level5 | GO:0032799 | low\-density lipoprotein receptor metabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
822 | Level5 | GO:0048569 | post\-embryonic organ development | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
823 | Level5 | GO:0001835 | blastocyst hatching | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
824 | Level4 | GO:0045777 | positive regulation of blood pressure | 2 | 1024 | 18 | 25236 | 1.83e-01 | 0.00 | 0.00 | 2.7 |
825 | Level5 | GO:0006760 | folic acid and derivative metabolic process | 2 | 1024 | 18 | 25236 | 1.83e-01 | 0.00 | 0.00 | 2.7 |
826 | Level5 | GO:0008542 | visual learning | 2 | 1024 | 19 | 25235 | 1.97e-01 | 0.00 | 0.00 | 2.6 |
827 | Level5 | GO:0065004 | protein\-DNA complex assembly | 6 | 1020 | 259 | 24995 | 2.01e-01 | 0.01 | 0.01 | 0.6 |
828 | Level4 | GO:0007625 | grooming behavior | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
829 | Level4 | GO:0048069 | eye pigmentation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
830 | Level5 | GO:0014002 | astrocyte development | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
831 | Level5 | GO:0007320 | insemination | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
832 | Level5 | GO:0048251 | elastic fiber assembly | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
833 | Level5 | GO:0048701 | embryonic cranial skeleton morphogenesis | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
834 | Level5 | GO:0009164 | nucleoside catabolic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
835 | Level5 | GO:0048483 | autonomic nervous system development | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
836 | Level5 | GO:0051546 | keratinocyte migration | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
837 | Level5 | GO:0048512 | circadian behavior | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
838 | Level5 | GO:0060073 | micturition | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
839 | Level5 | GO:0032506 | cytokinetic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
840 | Level5 | GO:0031579 | membrane raft organization and biogenesis | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
841 | Level5 | GO:0031503 | protein complex localization | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
842 | Level5 | GO:0040034 | regulation of development\, heterochronic | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
843 | Level5 | GO:0002244 | hemopoietic progenitor cell differentiation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
844 | Level4 | GO:0051181 | cofactor transport | 2 | 1024 | 21 | 25233 | 2.26e-01 | 0.00 | 0.00 | 2.3 |
845 | Level5 | GO:0007156 | homophilic cell adhesion | 10 | 1016 | 166 | 25088 | 2.36e-01 | 0.01 | 0.01 | 1.5 |
846 | Level3 | GO:0007632 | visual behavior | 2 | 1024 | 22 | 25232 | 2.41e-01 | 0.00 | 0.00 | 2.2 |
847 | Level5 | GO:0009311 | oligosaccharide metabolic process | 2 | 1024 | 22 | 25232 | 2.41e-01 | 0.00 | 0.00 | 2.2 |
848 | Level4 | GO:0001885 | endothelial cell development | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
849 | Level4 | GO:0001967 | suckling behavior | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
850 | Level4 | GO:0017145 | stem cell division | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
851 | Level4 | GO:0002209 | behavioral defense response | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
852 | Level5 | GO:0060117 | auditory receptor cell development | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
853 | Level5 | GO:0032607 | interferon\-alpha production | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
854 | Level5 | GO:0046685 | response to arsenic | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
855 | Level5 | GO:0007620 | copulation | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
856 | Level5 | GO:0045995 | regulation of embryonic development | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
857 | Level5 | GO:0008340 | determination of adult life span | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
858 | Level5 | GO:0035313 | wound healing\, spreading of epidermal cells | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
859 | Level5 | GO:0043043 | peptide biosynthetic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
860 | Level5 | GO:0007341 | penetration of zona pellucida | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
861 | Level5 | GO:0001662 | behavioral fear response | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
862 | Level5 | GO:0009583 | detection of light stimulus | 3 | 1023 | 41 | 25213 | 2.46e-01 | 0.00 | 0.00 | 1.8 |
863 | Level4 | GO:0006518 | peptide metabolic process | 2 | 1024 | 23 | 25231 | 2.55e-01 | 0.00 | 0.00 | 2.1 |
864 | Level5 | GO:0030216 | keratinocyte differentiation | 3 | 1023 | 42 | 25212 | 2.56e-01 | 0.00 | 0.00 | 1.8 |
865 | Level5 | GO:0009100 | glycoprotein metabolic process | 11 | 1015 | 187 | 25067 | 2.64e-01 | 0.01 | 0.01 | 1.4 |
866 | Level3 | GO:0051705 | behavioral interaction between organisms | 2 | 1024 | 24 | 25230 | 2.70e-01 | 0.00 | 0.00 | 2.1 |
867 | Level5 | GO:0046928 | regulation of neurotransmitter secretion | 2 | 1024 | 24 | 25230 | 2.70e-01 | 0.00 | 0.00 | 2.1 |
868 | Level3 | GO:0051236 | establishment of RNA localization | 1 | 1025 | 91 | 25163 | 2.72e-01 | 0.00 | 0.00 | 0.3 |
869 | Level4 | GO:0050658 | RNA transport | 1 | 1025 | 91 | 25163 | 2.72e-01 | 0.00 | 0.00 | 0.3 |
870 | Level5 | GO:0050657 | nucleic acid transport | 1 | 1025 | 91 | 25163 | 2.72e-01 | 0.00 | 0.00 | 0.3 |
871 | Level4 | GO:0060119 | inner ear receptor cell development | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
872 | Level4 | GO:0048286 | alveolus development | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
873 | Level4 | GO:0010259 | multicellular organismal aging | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
874 | Level4 | GO:0007622 | rhythmic behavior | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
875 | Level4 | GO:0060004 | reflex | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
876 | Level4 | GO:0002064 | epithelial cell development | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
877 | Level4 | GO:0048864 | stem cell development | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
878 | Level4 | GO:0017144 | drug metabolic process | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
879 | Level5 | GO:0060122 | inner ear receptor stereocilium organization and biogenesis | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
880 | Level5 | GO:0021895 | cerebral cortex neuron differentiation | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
881 | Level5 | GO:0042447 | hormone catabolic process | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
882 | Level5 | GO:0007029 | endoplasmic reticulum organization and biogenesis | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
883 | Level5 | GO:0021517 | ventral spinal cord development | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
884 | Level5 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
885 | Level5 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
886 | Level5 | GO:0003009 | skeletal muscle contraction | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
887 | Level4 | GO:0006403 | RNA localization | 1 | 1025 | 93 | 25161 | 2.75e-01 | 0.00 | 0.00 | 0.3 |
888 | Level4 | GO:0007516 | hemocyte development | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
889 | Level4 | GO:0015979 | photosynthesis | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
890 | Level5 | GO:0042074 | cell migration involved in gastrulation | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
891 | Level5 | GO:0048863 | stem cell differentiation | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
892 | Level4 | GO:0009582 | detection of abiotic stimulus | 4 | 1022 | 59 | 25195 | 3.12e-01 | 0.00 | 0.00 | 1.7 |
893 | Level5 | GO:0007600 | sensory perception | 44 | 982 | 934 | 24320 | 3.13e-01 | 0.04 | 0.04 | 1.2 |
894 | Level4 | GO:0001824 | blastocyst development | 2 | 1024 | 27 | 25227 | 3.14e-01 | 0.00 | 0.00 | 1.8 |
895 | Level4 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 2 | 1024 | 27 | 25227 | 3.14e-01 | 0.00 | 0.00 | 1.8 |
896 | Level3 | GO:0050879 | multicellular organismal movement | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
897 | Level4 | GO:0050881 | musculoskeletal movement | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
898 | Level4 | GO:0042596 | fear response | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
899 | Level4 | GO:0009791 | post\-embryonic development | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
900 | Level5 | GO:0015844 | monoamine transport | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
901 | Level5 | GO:0042386 | hemocyte differentiation | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
902 | Level5 | GO:0042461 | photoreceptor cell development | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
903 | Level5 | GO:0021515 | cell differentiation in spinal cord | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
904 | Level5 | GO:0050828 | regulation of liquid surface tension | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
905 | Level4 | GO:0019884 | antigen processing and presentation of exogenous antigen | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
906 | Level5 | GO:0046504 | glycerol ether biosynthetic process | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
907 | Level5 | GO:0014003 | oligodendrocyte development | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
908 | Level5 | GO:0021575 | hindbrain morphogenesis | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
909 | Level5 | GO:0048232 | male gamete generation | 14 | 1012 | 274 | 24980 | 3.59e-01 | 0.01 | 0.01 | 1.3 |
910 | Level4 | GO:0009581 | detection of external stimulus | 4 | 1022 | 67 | 25187 | 3.60e-01 | 0.00 | 0.00 | 1.5 |
911 | Level5 | GO:0007338 | single fertilization | 4 | 1022 | 67 | 25187 | 3.60e-01 | 0.00 | 0.00 | 1.5 |
912 | Level5 | GO:0051028 | mRNA transport | 1 | 1025 | 80 | 25174 | 3.80e-01 | 0.00 | 0.00 | 0.3 |
913 | Level5 | GO:0046530 | photoreceptor cell differentiation | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
914 | Level5 | GO:0002831 | regulation of response to biotic stimulus | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
915 | Level5 | GO:0007164 | establishment of tissue polarity | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
916 | Level5 | GO:0001832 | blastocyst growth | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
917 | Level5 | GO:0045682 | regulation of epidermis development | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
918 | Level5 | GO:0000045 | autophagic vacuole formation | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
919 | Level5 | GO:0007157 | heterophilic cell adhesion | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
920 | Level5 | GO:0009405 | pathogenesis | 3 | 1023 | 43 | 25211 | 4.27e-01 | 0.00 | 0.00 | 1.7 |
921 | Level4 | GO:0016236 | macroautophagy | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
922 | Level5 | GO:0008306 | associative learning | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
923 | Level4 | GO:0051321 | meiotic cell cycle | 5 | 1021 | 91 | 25163 | 4.28e-01 | 0.00 | 0.00 | 1.4 |
924 | Level4 | GO:0001539 | ciliary or flagellar motility | 3 | 1023 | 47 | 25207 | 4.46e-01 | 0.00 | 0.00 | 1.6 |
925 | Level4 | GO:0015931 | nucleobase\, nucleoside\, nucleotide and nucleic acid transport | 2 | 1024 | 106 | 25148 | 4.48e-01 | 0.00 | 0.00 | 0.5 |
926 | Level5 | GO:0003084 | positive regulation of systemic arterial blood pressure | 1 | 1025 | 14 | 25240 | 4.50e-01 | 0.00 | 0.00 | 1.8 |
927 | Level5 | GO:0035270 | endocrine system development | 3 | 1023 | 49 | 25205 | 4.57e-01 | 0.00 | 0.00 | 1.5 |
928 | Level4 | GO:0009595 | detection of biotic stimulus | 1 | 1025 | 16 | 25238 | 4.92e-01 | 0.00 | 0.00 | 1.5 |
929 | Level5 | GO:0007098 | centrosome cycle | 1 | 1025 | 16 | 25238 | 4.92e-01 | 0.00 | 0.00 | 1.5 |
930 | Level3 | GO:0033555 | multicellular organismal response to stress | 1 | 1025 | 17 | 25237 | 5.12e-01 | 0.00 | 0.00 | 1.4 |
931 | Level5 | GO:0021537 | telencephalon development | 1 | 1025 | 17 | 25237 | 5.12e-01 | 0.00 | 0.00 | 1.4 |
932 | Level5 | GO:0035036 | sperm\-egg recognition | 1 | 1025 | 17 | 25237 | 5.12e-01 | 0.00 | 0.00 | 1.4 |
933 | Level5 | GO:0009913 | epidermal cell differentiation | 1 | 1025 | 65 | 25189 | 5.22e-01 | 0.00 | 0.00 | 0.4 |
934 | Level4 | GO:0008038 | neuron recognition | 1 | 1025 | 18 | 25236 | 5.31e-01 | 0.00 | 0.00 | 1.4 |
935 | Level4 | GO:0009566 | fertilization | 4 | 1022 | 70 | 25184 | 5.37e-01 | 0.00 | 0.00 | 1.4 |
936 | Level5 | GO:0021983 | pituitary gland development | 1 | 1025 | 19 | 25235 | 5.49e-01 | 0.00 | 0.00 | 1.3 |
937 | Level4 | GO:0021536 | diencephalon development | 1 | 1025 | 20 | 25234 | 5.67e-01 | 0.00 | 0.00 | 1.2 |
938 | Level4 | GO:0009988 | cell\-cell recognition | 1 | 1025 | 20 | 25234 | 5.67e-01 | 0.00 | 0.00 | 1.2 |
939 | Level4 | GO:0009593 | detection of chemical stimulus | 1 | 1025 | 21 | 25233 | 5.84e-01 | 0.00 | 0.00 | 1.2 |
940 | Level5 | GO:0006775 | fat\-soluble vitamin metabolic process | 1 | 1025 | 21 | 25233 | 5.84e-01 | 0.00 | 0.00 | 1.2 |
941 | Level5 | GO:0031497 | chromatin assembly | 6 | 1020 | 201 | 25053 | 5.88e-01 | 0.01 | 0.01 | 0.7 |
942 | Level5 | GO:0019835 | cytolysis | 1 | 1025 | 22 | 25232 | 6.00e-01 | 0.00 | 0.00 | 1.1 |
943 | Level5 | GO:0042254 | ribosome biogenesis and assembly | 5 | 1021 | 98 | 25156 | 6.04e-01 | 0.00 | 0.00 | 1.3 |
944 | Level4 | GO:0006323 | DNA packaging | 7 | 1019 | 233 | 25021 | 6.13e-01 | 0.01 | 0.01 | 0.7 |
945 | Level3 | GO:0007623 | circadian rhythm | 2 | 1024 | 37 | 25217 | 6.65e-01 | 0.00 | 0.00 | 1.3 |
946 | Level3 | GO:0007059 | chromosome segregation | 2 | 1024 | 75 | 25179 | 7.71e-01 | 0.00 | 0.00 | 0.7 |
947 | Level5 | GO:0006412 | translation | 23 | 1003 | 539 | 24715 | 8.25e-01 | 0.02 | 0.02 | 1.1 |
948 | Level3 | GO:0006914 | autophagy | 1 | 1025 | 29 | 25225 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
949 | Level4 | GO:0022613 | ribonucleoprotein complex biogenesis and assembly | 9 | 1017 | 224 | 25030 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
950 | Level4 | GO:0015893 | drug transport | 1 | 1025 | 33 | 25221 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
951 | Level4 | GO:0046677 | response to antibiotic | 1 | 1025 | 30 | 25224 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
952 | Level4 | GO:0030317 | sperm motility | 1 | 1025 | 31 | 25223 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
953 | Level5 | GO:0022618 | protein\-RNA complex assembly | 5 | 1021 | 131 | 25123 | 1.00e+00 | 0.00 | 0.01 | 0.9 |
954 | Level5 | GO:0000819 | sister chromatid segregation | 1 | 1025 | 39 | 25215 | 1.00e+00 | 0.00 | 0.00 | 0.6 |
955 | Level5 | GO:0031099 | regeneration | 1 | 1025 | 24 | 25230 | 1.00e+00 | 0.00 | 0.00 | 1.0 |
956 | Level5 | GO:0016338 | calcium\-independent cell\-cell adhesion | 1 | 1025 | 36 | 25218 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
957 | Level5 | GO:0015904 | tetracycline transport | 1 | 1025 | 28 | 25226 | 1.00e+00 | 0.00 | 0.00 | 0.9 |
958 | Level5 | GO:0009799 | determination of symmetry | 1 | 1025 | 30 | 25224 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
959 | Level5 | GO:0009798 | axis specification | 1 | 1025 | 24 | 25230 | 1.00e+00 | 0.00 | 0.00 | 1.0 |